Component
Glycine
Independent small molecule record; interpretation is limited by each linked claim and its study context.
115 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Taurine-depleted cultured cells accumulated mitochondrial tRNA cmnm5U, whose glycine-derived group replaces the taurine-derived group of tau-m5U.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Mass spectrometry of mitochondrial tRNAs from depleted cells.
- limitations
- Detection of an alternative mark does not establish complete functional rescue by glycine.
- nutrient_topic
- Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
- plain_language
- Low taurine changed the chemical identity of the RNA modification.
- primary_references
- Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. · 2018 · https://pubmed.ncbi.nlm.nih.gov/29390138/ · DOI 10.1093/nar/gky068
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 241–247
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mass spectrometry of mitochondrial tRNAs from depleted cells. · source_derived_draft · unverified_draft
## taurine-glycine-substitution Low taurine changed the chemical identity of the RNA modification. Taurine-depleted cultured cells accumulated mitochondrial tRNA cmnm5U, whose glycine-derived group replaces the taurine-derived group of tau-m5U. Model: Mass spectrometry of mitochondrial tRNAs from depleted cells. Limitations: Detection of an alternative mark does not establish complete functional rescue by glycine. Evidence access: Primary abstract Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. · 2018 · https://pubmed.ncbi.nlm.nih.gov/29390138/ · DOI 10.1093/nar/gky068
Complete structured claim and evidenceIncreasing medium glycine from the millimolar range increased type-II collagen production in cultured bovine chondrocytes, with larger sustained effects than the tested proline/lysine increments.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Bovine articular chondrocyte monolayers; 15-day concentration series and collagen ELISA.
- limitations
- The paper proposes dietary implications, but the experiment does not establish human glycine essentiality, osteoarthritis causation or cartilage regeneration.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Collagen-producing cells responded to extra glycine in a culture assay.
- primary_references
- High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30006659/ · DOI 10.1007/s00726-018-2611-x
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 402–408
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Bovine articular chondrocyte monolayers; 15-day concentration series and collagen ELISA. · source_derived_draft · unverified_draft
## glycine-collagen-culture Collagen-producing cells responded to extra glycine in a culture assay. Increasing medium glycine from the millimolar range increased type-II collagen production in cultured bovine chondrocytes, with larger sustained effects than the tested proline/lysine increments. Model: Bovine articular chondrocyte monolayers; 15-day concentration series and collagen ELISA. Limitations: The paper proposes dietary implications, but the experiment does not establish human glycine essentiality, osteoarthritis causation or cartilage regeneration. Evidence access: Primary full text High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30006659/ · DOI 10.1007/s00726-018-2611-x
Complete structured claim and evidenceGlycine alone did not restore hemoglobin in the zebrafish Slc25a38 congenital-sideroblastic-anemia model.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Zebrafish Slc25a38-deficiency model with supplementation.
- limitations
- Species, folate synthesis and exposure differ from yeast; a context difference is not a fabricated contradiction.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The single-ingredient rescue did not transfer from yeast to this animal model.
- primary_references
- Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia. · 2016 · https://pubmed.ncbi.nlm.nih.gov/26821380/ · DOI 10.1371/journal.pgen.1005783
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 98–104
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Zebrafish Slc25a38-deficiency model with supplementation. · source_derived_draft · unverified_draft
## glycine-fish-glycine-alone The single-ingredient rescue did not transfer from yeast to this animal model. Glycine alone did not restore hemoglobin in the zebrafish Slc25a38 congenital-sideroblastic-anemia model. Model: Zebrafish Slc25a38-deficiency model with supplementation. Limitations: Species, folate synthesis and exposure differ from yeast; a context difference is not a fabricated contradiction. Evidence access: Primary full text Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia. · 2016 · https://pubmed.ncbi.nlm.nih.gov/26821380/ · DOI 10.1371/journal.pgen.1005783
Complete structured claim and evidenceWith serine absent, higher glycine concentrations inhibited growth and glycine was converted to serine, a reaction consuming one-carbon units.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cancer cultures deprived of serine, glycine exposure and metabolic analysis.
- limitations
- No exposure threshold for humans is derived; one-carbon depletion is the pathway interpretation supported by the rescue experiment.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Using glycine to rebuild missing serine can draw from the folate carbon pool.
- primary_references
- Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24813884/ · DOI 10.1016/j.celrep.2014.04.045
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 178–184
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cancer cultures deprived of serine, glycine exposure and metabolic analysis. · source_derived_draft · unverified_draft
## glycine-glycine-reverse-flux Using glycine to rebuild missing serine can draw from the folate carbon pool. With serine absent, higher glycine concentrations inhibited growth and glycine was converted to serine, a reaction consuming one-carbon units. Model: Cancer cultures deprived of serine, glycine exposure and metabolic analysis. Limitations: No exposure threshold for humans is derived; one-carbon depletion is the pathway interpretation supported by the rescue experiment. Evidence access: Primary abstract Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24813884/ · DOI 10.1016/j.celrep.2014.04.045
Complete structured claim and evidenceAt saturating 30 mM agonist, human alpha1 glycine-receptor activation rose faster with glycine than beta-alanine or taurine, and glycine responses decayed more slowly after removal.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human recombinant receptor comparison using high agonist concentrations.
- limitations
- Not equivalent to relative sedative potency after oral intake.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Related molecules activate the same receptor with different timing.
- primary_references
- Kinetic determinants of agonist action at the recombinant human glycine receptor. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12679369/ · DOI 10.1113/jphysiol.2002.037796
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 202–208
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human recombinant receptor comparison using high agonist concentrations. · source_derived_draft · unverified_draft
## glycine-glyr-ligand-kinetics Related molecules activate the same receptor with different timing. At saturating 30 mM agonist, human alpha1 glycine-receptor activation rose faster with glycine than beta-alanine or taurine, and glycine responses decayed more slowly after removal. Model: Human recombinant receptor comparison using high agonist concentrations. Limitations: Not equivalent to relative sedative potency after oral intake. Evidence access: Primary abstract Kinetic determinants of agonist action at the recombinant human glycine receptor. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12679369/ · DOI 10.1113/jphysiol.2002.037796
Complete structured claim and evidenceGlycine opened recombinant human alpha1 homomeric glycine receptors in HEK293 cells; rapid-application and single-channel assays resolved activation kinetics.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human alpha1 receptor, rapid agonist application and patch recording.
- limitations
- Homomeric experimental receptor differs from native heteromeric receptor mixtures; chloride gradient determines current consequences.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Glycine can directly open a receptor channel.
- primary_references
- Kinetic determinants of agonist action at the recombinant human glycine receptor. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12679369/ · DOI 10.1113/jphysiol.2002.037796
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 194–200
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human alpha1 receptor, rapid agonist application and patch recording. · source_derived_draft · unverified_draft
## glycine-glyr-opening Glycine can directly open a receptor channel. Glycine opened recombinant human alpha1 homomeric glycine receptors in HEK293 cells; rapid-application and single-channel assays resolved activation kinetics. Model: Human alpha1 receptor, rapid agonist application and patch recording. Limitations: Homomeric experimental receptor differs from native heteromeric receptor mixtures; chloride gradient determines current consequences. Evidence access: Primary abstract Kinetic determinants of agonist action at the recombinant human glycine receptor. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12679369/ · DOI 10.1113/jphysiol.2002.037796
Complete structured claim and evidenceRadioligand binding and mutagenesis supported direct glycine recognition by the GPR158 Cache domain, with an estimated binding Kd near 3 micromolar in receptor-expressing membranes.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Recombinant GPR158 in HEK293-derived membrane binding assays.
- limitations
- Construct species is not resolved by the accessed main-text methods; human host cells do not establish human receptor sequence. Binding Kd is not an oral dose.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Glycine has a receptor beyond its familiar chloride channel and NMDA site.
- primary_references
- Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 218–224
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant GPR158 in HEK293-derived membrane binding assays. · source_derived_draft · unverified_draft
## glycine-gpr158-binding Glycine has a receptor beyond its familiar chloride channel and NMDA site. Radioligand binding and mutagenesis supported direct glycine recognition by the GPR158 Cache domain, with an estimated binding Kd near 3 micromolar in receptor-expressing membranes. Model: Recombinant GPR158 in HEK293-derived membrane binding assays. Limitations: Construct species is not resolved by the accessed main-text methods; human host cells do not establish human receptor sequence. Binding Kd is not an oral dose. Evidence access: Primary full text Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Complete structured claim and evidenceIn mouse accumbens slices, 1 mM glycine increased medium-spiny-neuron firing and reduced M-current amplitude; a selective M-current inhibitor mimicked and occluded the response.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Male C57BL/6J mice aged four to six weeks; slice patch clamp with synaptic blockers.
- limitations
- Authors attributed the response to GPR158; pharmacology alone is weaker than a receptor-knockout test and does not prove direct channel binding.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Glycine-sensitive signaling intersects with potassium-channel control of firing.
- primary_references
- Glycine-induced activation of GPR158 increases the intrinsic excitability of medium spiny neurons in the nucleus accumbens. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38884814/ · DOI 10.1007/s00018-024-05260-w
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 258–264
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Male C57BL/6J mice aged four to six weeks; slice patch clamp with synaptic blockers. · source_derived_draft · unverified_draft
## glycine-gpr158-potassium-current Glycine-sensitive signaling intersects with potassium-channel control of firing. In mouse accumbens slices, 1 mM glycine increased medium-spiny-neuron firing and reduced M-current amplitude; a selective M-current inhibitor mimicked and occluded the response. Model: Male C57BL/6J mice aged four to six weeks; slice patch clamp with synaptic blockers. Limitations: Authors attributed the response to GPR158; pharmacology alone is weaker than a receptor-knockout test and does not prove direct channel binding. Evidence access: Primary full text Glycine-induced activation of GPR158 increases the intrinsic excitability of medium spiny neurons in the nucleus accumbens. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38884814/ · DOI 10.1007/s00018-024-05260-w
Complete structured claim and evidenceGlycine slowed G-alpha-o deactivation only when GPR158 was coexpressed with RGS7/G-beta5, supporting inhibition of the complex's GTPase-accelerating activity.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Recombinant cellular BRET assays, including 100 micromolar glycine comparisons.
- limitations
- Functional coupling does not prove every intervening conformational step or a clinical mood effect.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Receptor binding changes how quickly another signaling switch is turned off.
- primary_references
- Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 226–232
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant cellular BRET assays, including 100 micromolar glycine comparisons. · source_derived_draft · unverified_draft
## glycine-gpr158-rgs-inhibition Receptor binding changes how quickly another signaling switch is turned off. Glycine slowed G-alpha-o deactivation only when GPR158 was coexpressed with RGS7/G-beta5, supporting inhibition of the complex's GTPase-accelerating activity. Model: Recombinant cellular BRET assays, including 100 micromolar glycine comparisons. Limitations: Functional coupling does not prove every intervening conformational step or a clinical mood effect. Evidence access: Primary full text Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Complete structured claim and evidenceSupplementing 5 mM glycine restored heme levels in yeast lacking Hem25 in the reported experiment.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Yeast hem25 deletion with glycine or 5-aminolevulinate supplementation.
- limitations
- Yeast has alternative pathways and synthesizes folate; this is not a human treatment result.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Extra substrate bypassed part of a transport bottleneck in yeast.
- primary_references
- Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia. · 2016 · https://pubmed.ncbi.nlm.nih.gov/26821380/ · DOI 10.1371/journal.pgen.1005783
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 90–96
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Yeast hem25 deletion with glycine or 5-aminolevulinate supplementation. · source_derived_draft · unverified_draft
## glycine-hem25-glycine-rescue Extra substrate bypassed part of a transport bottleneck in yeast. Supplementing 5 mM glycine restored heme levels in yeast lacking Hem25 in the reported experiment. Model: Yeast hem25 deletion with glycine or 5-aminolevulinate supplementation. Limitations: Yeast has alternative pathways and synthesizes folate; this is not a human treatment result. Evidence access: Primary full text Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia. · 2016 · https://pubmed.ncbi.nlm.nih.gov/26821380/ · DOI 10.1371/journal.pgen.1005783
Complete structured claim and evidenceIncreasing glycine did not increase N-isovalerylglycine formation in the reported in-vitro conjugation experiments.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- GLYAT/GLYATL1 enzyme experiments.
- limitations
- Not evidence that glycine treatment never works in isovaleric acidemia; substrate, enzyme and kinetic context matter.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Adding substrate did not keep increasing this disposal reaction.
- primary_references
- The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36817957/ · DOI 10.1016/j.csbj.2023.01.041
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 306–312
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · GLYAT/GLYATL1 enzyme experiments. · source_derived_draft · unverified_draft
## glycine-isovaleryl-glycine-limit Adding substrate did not keep increasing this disposal reaction. Increasing glycine did not increase N-isovalerylglycine formation in the reported in-vitro conjugation experiments. Model: GLYAT/GLYATL1 enzyme experiments. Limitations: Not evidence that glycine treatment never works in isovaleric acidemia; substrate, enzyme and kinetic context matter. Evidence access: Primary full text The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36817957/ · DOI 10.1016/j.csbj.2023.01.041
Complete structured claim and evidenceGlycine at 1 mM nearly prevented the calcium rise elicited by 10 micrograms/mL LPS in cultured rat Kupffer cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat Kupffer-cell culture with glycine, LPS and receptor pharmacology.
- limitations
- High in-vitro exposure; not a demonstrated systemic anti-inflammatory effect in humans.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Glycine changed a calcium signal in liver immune cells.
- primary_references
- Kupffer cells contain a glycine-gated chloride channel. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9227496/ · DOI 10.1152/ajpgi.1997.272.6.G1581
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 330–336
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat Kupffer-cell culture with glycine, LPS and receptor pharmacology. · source_derived_draft · unverified_draft
## glycine-kupffer-calcium Glycine changed a calcium signal in liver immune cells. Glycine at 1 mM nearly prevented the calcium rise elicited by 10 micrograms/mL LPS in cultured rat Kupffer cells. Model: Rat Kupffer-cell culture with glycine, LPS and receptor pharmacology. Limitations: High in-vitro exposure; not a demonstrated systemic anti-inflammatory effect in humans. Evidence access: Primary abstract Kupffer cells contain a glycine-gated chloride channel. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9227496/ · DOI 10.1152/ajpgi.1997.272.6.G1581
Complete structured claim and evidenceGlycine reduced LPS-associated TNF-alpha production in cultured rat Kupffer cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat cell-culture LPS challenge.
- limitations
- The cell assay does not establish a clinical effect or prove all intermediary steps.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A signaling change accompanied lower inflammatory-mediator output.
- primary_references
- Kupffer cells contain a glycine-gated chloride channel. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9227496/ · DOI 10.1152/ajpgi.1997.272.6.G1581
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 346–352
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat cell-culture LPS challenge. · source_derived_draft · unverified_draft
## glycine-kupffer-tnf A signaling change accompanied lower inflammatory-mediator output. Glycine reduced LPS-associated TNF-alpha production in cultured rat Kupffer cells. Model: Rat cell-culture LPS challenge. Limitations: The cell assay does not establish a clinical effect or prove all intermediary steps. Evidence access: Primary abstract Kupffer cells contain a glycine-gated chloride channel. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9227496/ · DOI 10.1152/ajpgi.1997.272.6.G1581
Complete structured claim and evidenceIn primary human macrophages, 50 mM glycine inhibited pyroptosis-associated NINJ1 clustering and membrane rupture; NINJ1 knockdown produced a similar rupture phenotype.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human monocyte-derived macrophages, LPS/nigericin, native-protein analysis and knockdown.
- limitations
- Direct or indirect target engagement remains unresolved; 50 mM bath exposure is not a dietary plasma concentration.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The membrane effect also occurred in human cells at a much higher experimental exposure.
- primary_references
- Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36468682/ · DOI 10.7554/eLife.78609
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 362–368
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human monocyte-derived macrophages, LPS/nigericin, native-protein analysis and knockdown. · source_derived_draft · unverified_draft
## glycine-ninj1-human-clustering The membrane effect also occurred in human cells at a much higher experimental exposure. In primary human macrophages, 50 mM glycine inhibited pyroptosis-associated NINJ1 clustering and membrane rupture; NINJ1 knockdown produced a similar rupture phenotype. Model: Human monocyte-derived macrophages, LPS/nigericin, native-protein analysis and knockdown. Limitations: Direct or indirect target engagement remains unresolved; 50 mM bath exposure is not a dietary plasma concentration. Evidence access: Primary full text Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36468682/ · DOI 10.7554/eLife.78609
Complete structured claim and evidenceGlycine at 5 mM reduced LDH release in mouse macrophages undergoing tested pyroptotic, necrotic and post-apoptotic lysis, with no additional protection in Ninj1-knockout cells.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Mouse iBMDM knockout and glycine comparisons; stimulus-specific exposure durations.
- limitations
- No-additivity supports a shared process, not proof of direct glycine binding to NINJ1.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A late membrane-rupture step was inhibited across several injury models.
- primary_references
- Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36468682/ · DOI 10.7554/eLife.78609
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 354–360
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse iBMDM knockout and glycine comparisons; stimulus-specific exposure durations. · source_derived_draft · unverified_draft
## glycine-ninj1-mouse A late membrane-rupture step was inhibited across several injury models. Glycine at 5 mM reduced LDH release in mouse macrophages undergoing tested pyroptotic, necrotic and post-apoptotic lysis, with no additional protection in Ninj1-knockout cells. Model: Mouse iBMDM knockout and glycine comparisons; stimulus-specific exposure durations. Limitations: No-additivity supports a shared process, not proof of direct glycine binding to NINJ1. Evidence access: Primary full text Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36468682/ · DOI 10.7554/eLife.78609
Complete structured claim and evidenceGlycine did not protect primary human macrophages from the tested zVAD/BV6/TNF-induced necroptotic rupture.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Primary human macrophages under a defined necroptosis protocol.
- limitations
- Different death execution pathways explain a context boundary; do not label this a conflicting replication of pyroptosis.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The same protection did not apply to every route of cell death.
- primary_references
- Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36468682/ · DOI 10.7554/eLife.78609
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 378–384
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary human macrophages under a defined necroptosis protocol. · source_derived_draft · unverified_draft
## glycine-ninj1-necroptosis-limit The same protection did not apply to every route of cell death. Glycine did not protect primary human macrophages from the tested zVAD/BV6/TNF-induced necroptotic rupture. Model: Primary human macrophages under a defined necroptosis protocol. Limitations: Different death execution pathways explain a context boundary; do not label this a conflicting replication of pyroptosis. Evidence access: Primary full text Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36468682/ · DOI 10.7554/eLife.78609
Complete structured claim and evidenceHuman pyroptotic macrophages protected from rupture by glycine still lost mitochondrial membrane potential and ATP.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Primary human macrophage energy/viability measurements alongside LDH assays.
- limitations
- The outcome is suppression of rupture, not reversal of upstream cell death.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- An intact membrane did not mean the cell survived.
- primary_references
- Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36468682/ · DOI 10.7554/eLife.78609
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 370–376
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary human macrophage energy/viability measurements alongside LDH assays. · source_derived_draft · unverified_draft
## glycine-ninj1-viability-limit An intact membrane did not mean the cell survived. Human pyroptotic macrophages protected from rupture by glycine still lost mitochondrial membrane potential and ATP. Model: Primary human macrophage energy/viability measurements alongside LDH assays. Limitations: The outcome is suppression of rupture, not reversal of upstream cell death. Evidence access: Primary full text Glycine inhibits NINJ1 membrane clustering to suppress plasma membrane rupture in cell death. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36468682/ · DOI 10.7554/eLife.78609
Complete structured claim and evidenceCarbon-labeled glycine entered purine nucleotides in LOX IMVI cells; positional tracing supported direct glycine incorporation rather than glycine-cleavage-derived one-carbon incorporation in that setting.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human LOX IMVI and A498 cancer cultures; positional isotope tracing.
- limitations
- This experiment does not measure glycine-cleavage flux in every cell type.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- An amino acid can supply part of a DNA/RNA building block directly.
- primary_references
- Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22628656/ · DOI 10.1126/science.1218595
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 146–152
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human LOX IMVI and A498 cancer cultures; positional isotope tracing. · source_derived_draft · unverified_draft
## glycine-purine-incorporation An amino acid can supply part of a DNA/RNA building block directly. Carbon-labeled glycine entered purine nucleotides in LOX IMVI cells; positional tracing supported direct glycine incorporation rather than glycine-cleavage-derived one-carbon incorporation in that setting. Model: Human LOX IMVI and A498 cancer cultures; positional isotope tracing. Limitations: This experiment does not measure glycine-cleavage flux in every cell type. Evidence access: Primary full text Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22628656/ · DOI 10.1126/science.1218595
Complete structured claim and evidenceIn the tested cancer cultures, exogenous glycine did not replace serine for nucleotide synthesis and proliferation; glycine restriction or glycine-cleavage depletion did not impede growth.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Primary cancer-cell nutrient-restriction and metabolic tracing study.
- limitations
- Abstract-level extraction; model-specific result does not negate glycine-dependent growth in other culture conditions.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The ability to interconvert two amino acids does not make their supplies interchangeable.
- primary_references
- Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24813884/ · DOI 10.1016/j.celrep.2014.04.045
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 170–176
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary cancer-cell nutrient-restriction and metabolic tracing study. · source_derived_draft · unverified_draft
## glycine-serine-required-context The ability to interconvert two amino acids does not make their supplies interchangeable. In the tested cancer cultures, exogenous glycine did not replace serine for nucleotide synthesis and proliferation; glycine restriction or glycine-cleavage depletion did not impede growth. Model: Primary cancer-cell nutrient-restriction and metabolic tracing study. Limitations: Abstract-level extraction; model-specific result does not negate glycine-dependent growth in other culture conditions. Evidence access: Primary abstract Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24813884/ · DOI 10.1016/j.celrep.2014.04.045
Complete structured claim and evidenceIn a randomized single-blind crossover study analyzing seven healthy men after partial sleep restriction, 3 g bedtime glycine improved reported fatigue and psychomotor vigilance measures.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Ten male company employees enrolled, seven analyzed; 25% sleep restriction for three nights, glycine or placebo 30 minutes before bed.
- limitations
- Small selected sample, short duration and industry setting limit generalization; rat SCN experiments do not prove the human mechanism.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A small human experiment measured next-day performance rather than proving a molecular pathway.
- primary_references
- The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22529837/ · DOI 10.3389/fneur.2012.00061
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 426–432
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Ten male company employees enrolled, seven analyzed; 25% sleep restriction for three nights, glycine or placebo 30 minutes before bed. · source_derived_draft · unverified_draft
## glycine-sleep-human-outcomes A small human experiment measured next-day performance rather than proving a molecular pathway. In a randomized single-blind crossover study analyzing seven healthy men after partial sleep restriction, 3 g bedtime glycine improved reported fatigue and psychomotor vigilance measures. Model: Ten male company employees enrolled, seven analyzed; 25% sleep restriction for three nights, glycine or placebo 30 minutes before bed. Limitations: Small selected sample, short duration and industry setting limit generalization; rat SCN experiments do not prove the human mechanism. Evidence access: Primary full text The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22529837/ · DOI 10.3389/fneur.2012.00061
Complete structured claim and evidenceGlycine increased cutaneous blood flow and promoted sleep in the rat experiments; SCN ablation abolished the reported sleep-promoting and hypothermic responses.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat oral, intracerebral and SCN-ablation experiments.
- limitations
- The routes are not interchangeable; abstract-level extraction does not establish the human mediation mechanism.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A brain circuit connected the amino-acid intervention with body heat loss.
- primary_references
- The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25533534/ · DOI 10.1038/npp.2014.326
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 410–416
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat oral, intracerebral and SCN-ablation experiments. · source_derived_draft · unverified_draft
## glycine-sleep-rat-scn A brain circuit connected the amino-acid intervention with body heat loss. Glycine increased cutaneous blood flow and promoted sleep in the rat experiments; SCN ablation abolished the reported sleep-promoting and hypothermic responses. Model: Rat oral, intracerebral and SCN-ablation experiments. Limitations: The routes are not interchangeable; abstract-level extraction does not establish the human mediation mechanism. Evidence access: Primary abstract The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25533534/ · DOI 10.1038/npp.2014.326
Complete structured claim and evidenceKynurenic-acid NMDA-blocking IC50 shifted from about 15 to 235 micromolar when 10 micromolar glycine was present.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat neuronal electrophysiological assay.
- limitations
- An assay co-agonist effect does not show that glycine supplements change human disease outcomes.
- nutrient_topic
- Tryptophan collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Tryptophan
- plain_language
- A second amino acid changed how strongly the metabolite blocked a receptor.
- primary_references
- The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11567036/ · DOI 10.1523/JNEUROSCI.21-19-07463.2001
Tryptophan: transport, protein synthesis, neuroactive metabolites, NAD and microbial pathways (2026-09-19) · lines 314–320
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Rat neuronal electrophysiological assay. · source_derived_draft · unverified_draft
## tryptophan-glycine-kyna-nmda A second amino acid changed how strongly the metabolite blocked a receptor. Kynurenic-acid NMDA-blocking IC50 shifted from about 15 to 235 micromolar when 10 micromolar glycine was present. Model: Rat neuronal electrophysiological assay. Limitations: An assay co-agonist effect does not show that glycine supplements change human disease outcomes. Evidence access: Primary abstract The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11567036/ · DOI 10.1523/JNEUROSCI.21-19-07463.2001
Complete structured claim and evidenceIntracellular glycine tonically inhibited serine racemase in the study, while glycine exposure could transiently promote D-serine release through Asc-1.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Biochemical assays, primary cultures and mouse microdialysis; Asc-1 knockout abolished the release response.
- limitations
- Inhibition of synthesis and stimulation of release are distinct endpoints, not contradictory directions for one reaction.
- nutrient_topic
- L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Serine
- plain_language
- The same neighboring amino acid can affect both production and release in different ways.
- primary_references
- The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31548413/ · DOI 10.1073/pnas.1909458116
L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19) · lines 358–364
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Biochemical assays, primary cultures and mouse microdialysis; Asc-1 knockout abolished the release response. · source_derived_draft · unverified_draft
## l-serine-glycine-racemase The same neighboring amino acid can affect both production and release in different ways. Intracellular glycine tonically inhibited serine racemase in the study, while glycine exposure could transiently promote D-serine release through Asc-1. Model: Biochemical assays, primary cultures and mouse microdialysis; Asc-1 knockout abolished the release response. Limitations: Inhibition of synthesis and stimulation of release are distinct endpoints, not contradictory directions for one reaction. Evidence access: Primary abstract The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31548413/ · DOI 10.1073/pnas.1909458116
Complete structured claim and evidenceSpermidine uptake through the tested NMDA receptors required glycine and glutamate.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Heterologous receptor transport assays.
- limitations
- Requirement is for receptor activation, not evidence for an oral supplement combination.
- nutrient_topic
- Spermidine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Spermidine
- plain_language
- Other amino acids gate this entry route.
- primary_references
- Spermidine and Ca(2+), but not Na(+), can permeate NMDA receptors consisting of GluN1 and GluN2A or GluN2B in the presence of Mg(2+). · 2015 · https://pubmed.ncbi.nlm.nih.gov/26086092/ · DOI 10.1016/j.bbrc.2015.06.081
Spermidine: biosynthesis, hypusination, transport and cross-nutrient mechanisms (2026-09-19) · lines 454–460
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Heterologous receptor transport assays. · source_derived_draft · unverified_draft
## spermidine-nmda-ligands Other amino acids gate this entry route. Spermidine uptake through the tested NMDA receptors required glycine and glutamate. Model: Heterologous receptor transport assays. Limitations: Requirement is for receptor activation, not evidence for an oral supplement combination. Evidence access: Primary abstract Spermidine and Ca(2+), but not Na(+), can permeate NMDA receptors consisting of GluN1 and GluN2A or GluN2B in the presence of Mg(2+). · 2015 · https://pubmed.ncbi.nlm.nih.gov/26086092/ · DOI 10.1016/j.bbrc.2015.06.081
Complete structured claim and evidenceGlycine increased opening frequency of NMDA-activated channels in cultured mouse brain neurons, with potentiation detected at 10 nM.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Mouse cultured neurons and outside-out patch recordings.
- limitations
- The effect was distinct from strychnine-sensitive glycine receptors; it does not define an oral glycine or glutamate response.
- nutrient_topic
- L-Glutamate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Glutamate
- plain_language
- An amino acid usually associated with inhibition can assist an excitatory receptor.
- primary_references
- Glycine potentiates the NMDA response in cultured mouse brain neurons. · 1987 · https://pubmed.ncbi.nlm.nih.gov/2433595/ · DOI 10.1038/325529a0
L-Glutamate / L-glutamic acid: carbon and nitrogen allocation, signaling and cross-nutrient mechanisms (2026-09-19) · lines 234–240
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse cultured neurons and outside-out patch recordings. · source_derived_draft · unverified_draft
## glutamate-nmda-glycine An amino acid usually associated with inhibition can assist an excitatory receptor. Glycine increased opening frequency of NMDA-activated channels in cultured mouse brain neurons, with potentiation detected at 10 nM. Model: Mouse cultured neurons and outside-out patch recordings. Limitations: The effect was distinct from strychnine-sensitive glycine receptors; it does not define an oral glycine or glutamate response. Evidence access: Primary abstract Glycine potentiates the NMDA response in cultured mouse brain neurons. · 1987 · https://pubmed.ncbi.nlm.nih.gov/2433595/ · DOI 10.1038/325529a0
Complete structured claim and evidenceIsolated mouse embryonic mitochondria converted labeled glycine carbon into formate.
Experimental context and source evidence
- cross_nutrient
- Handoff to existing PLP-dependent glycine decarboxylase and lipoyl-GCSH/AMT folate transfer evidence; not new deficiency evidence.
- experimental_model
- Radiolabeled mitochondrial flux assay
- exposure
- Assay conditions described in the linked primary study.
- limitations
- No B6 or lipoate dietary perturbation tested.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Mus musculus
- plain_language
- Glycine cleavage can feed folate-bound carbon into mitochondrial formate production.
- primary_references
- [pike-2010] Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos (2010). https://pubmed.ncbi.nlm.nih.gov/19948730/ DOI: 10.1074/jbc.m109.079855
- tissue_or_cell_type
- Embryonic mitochondria
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1096–1107
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiolabeled mitochondrial flux assay · source_derived_draft · unverified_draft
### embryonic-glycine-formate Isolated mouse embryonic mitochondria converted labeled glycine carbon into formate. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Glycine cleavage can feed folate-bound carbon into mitochondrial formate production. organism: Mus musculus tissue_or_cell_type: Embryonic mitochondria experimental_model: Radiolabeled mitochondrial flux assay limitations: No B6 or lipoate dietary perturbation tested. exposure: Assay conditions described in the linked primary study. cross_nutrient: Handoff to existing PLP-dependent glycine decarboxylase and lipoyl-GCSH/AMT folate transfer evidence; not new deficiency evidence. [pike-2010] Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos (2010). https://pubmed.ncbi.nlm.nih.gov/19948730/ DOI: 10.1074/jbc.m109.079855
Complete structured claim and evidence
What acts on it
Chicken P-protein alone catalyzed very slow glycine decarboxylation; added lipoic acid stimulated the measured decarboxylation at least 100-fold.
Experimental context and source evidence
- cross_nutrient
- PLP chemistry connects with the lipoyl component of glycine cleavage.
- experimental_model
- Purified chicken liver mitochondrial P-protein
- limitations
- Free lipoic acid assay; not evidence that supplements replace the intact cleavage system.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Gallus gallus
- plain_language
- B6-dependent glycine cleavage also depends on its lipoyl-linked reaction partners.
- primary_references
- [b6-gldc-1980] The mitochondrial glycine cleavage system. Purification and properties of glycine decarboxylase from chicken liver mitochondria. (1980). https://pubmed.ncbi.nlm.nih.gov/7440562/ DOI: 10.1016/s0021-9258(19)70183-5
- tissue_or_cell_type
- Chicken liver mitochondrial protein
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 659–669
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified chicken liver mitochondrial P-protein · source_derived_draft · unverified_draft
### b6-met-chicken-gldc-decarboxylation Chicken P-protein alone catalyzed very slow glycine decarboxylation; added lipoic acid stimulated the measured decarboxylation at least 100-fold. Condition category: normal nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: B6-dependent glycine cleavage also depends on its lipoyl-linked reaction partners. organism: Gallus gallus tissue_or_cell_type: Chicken liver mitochondrial protein experimental_model: Purified chicken liver mitochondrial P-protein limitations: Free lipoic acid assay; not evidence that supplements replace the intact cleavage system. cross_nutrient: PLP chemistry connects with the lipoyl component of glycine cleavage. [b6-gldc-1980] The mitochondrial glycine cleavage system. Purification and properties of glycine decarboxylase from chicken liver mitochondria. (1980). https://pubmed.ncbi.nlm.nih.gov/7440562/ DOI: 10.1016/s0021-9258(19)70183-5
Complete structured claim and evidenceHuman GlyT1 expressed in COS-7 cells transported glycine with sodium and chloride; the kinetic analysis used the established 2 Na+:1 Cl-:1 glycine coupling.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human transporter in nonhuman COS-7 host cells; whole-cell electrophysiology, usually 1 mM glycine.
- limitations
- The stoichiometry is established background incorporated into this primary kinetic study; no dietary salt intervention. Human protein and host-cell species differ.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Glycine uptake draws on ion gradients, not just the amount of amino acid outside.
- primary_references
- A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31270129/ · DOI 10.1085/jgp.201912318
- transport_effect
- raises Sodium- and chloride-coupled glycine transport, which is inward.
- transport_pool
- the expressing cell Sodium- and chloride-coupled glycine transport, which is inward.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 26–32
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human transporter in nonhuman COS-7 host cells; whole-cell electrophysiology, usually 1 mM glycine. · source_derived_draft · unverified_draft
## glycine-glyt1-transport Glycine uptake draws on ion gradients, not just the amount of amino acid outside. Human GlyT1 expressed in COS-7 cells transported glycine with sodium and chloride; the kinetic analysis used the established 2 Na+:1 Cl-:1 glycine coupling. Model: Human transporter in nonhuman COS-7 host cells; whole-cell electrophysiology, usually 1 mM glycine. Limitations: The stoichiometry is established background incorporated into this primary kinetic study; no dietary salt intervention. Human protein and host-cell species differ. Evidence access: Primary full text A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31270129/ · DOI 10.1085/jgp.201912318
Complete structured claim and evidenceHuman GlyT2 expressed in COS-7 cells supported sodium/chloride-coupled glycine uptake; the study modeled its established 3 Na+:1 Cl-:1 glycine stoichiometry.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human recombinant GlyT2, voltage clamp and kinetic modeling.
- limitations
- Methods refer to GlyT2a and a purchased GlyT2b plasmid; this record stays at gene level rather than resolving that isoform discrepancy by guesswork.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A second transporter uses a different ion coupling to accumulate the same substrate.
- primary_references
- A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31270129/ · DOI 10.1085/jgp.201912318
- transport_effect
- raises Recorded as sodium/chloride-coupled glycine uptake.
- transport_pool
- the expressing cell Recorded as sodium/chloride-coupled glycine uptake.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 34–40
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human recombinant GlyT2, voltage clamp and kinetic modeling. · source_derived_draft · unverified_draft
## glycine-glyt2-transport A second transporter uses a different ion coupling to accumulate the same substrate. Human GlyT2 expressed in COS-7 cells supported sodium/chloride-coupled glycine uptake; the study modeled its established 3 Na+:1 Cl-:1 glycine stoichiometry. Model: Human recombinant GlyT2, voltage clamp and kinetic modeling. Limitations: Methods refer to GlyT2a and a purchased GlyT2b plasmid; this record stays at gene level rather than resolving that isoform discrepancy by guesswork. Evidence access: Primary full text A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31270129/ · DOI 10.1085/jgp.201912318
Complete structured claim and evidenceThe biochemical characterization reported glycine transport by human SLC25A38; human SLC25A38 expression complemented heme-pathway defects in yeast lacking Hem25.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human/yeast carrier biochemistry and yeast genetic complementation.
- limitations
- Primary abstract access; later PLP-homeostasis findings broaden interpretation. This claim does not establish exclusive substrate specificity.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A mitochondrial carrier connects access to glycine with heme production.
- primary_references
- Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27476175/ · DOI 10.1074/jbc.M116.736876
- transport_effect
- raises Human expression complemented heme-pathway defects in yeast lacking Hem25, which is matrix glycine supply.
- transport_pool
- the mitochondrial matrix Human expression complemented heme-pathway defects in yeast lacking Hem25, which is matrix glycine supply.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 82–88
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human/yeast carrier biochemistry and yeast genetic complementation. · source_derived_draft · unverified_draft
## glycine-s38-glycine-transport A mitochondrial carrier connects access to glycine with heme production. The biochemical characterization reported glycine transport by human SLC25A38; human SLC25A38 expression complemented heme-pathway defects in yeast lacking Hem25. Model: Human/yeast carrier biochemistry and yeast genetic complementation. Limitations: Primary abstract access; later PLP-homeostasis findings broaden interpretation. This claim does not establish exclusive substrate specificity. Evidence access: Primary abstract Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27476175/ · DOI 10.1074/jbc.M116.736876
Complete structured claim and evidenceSlc6a20a-knockout mice had higher extracellular brain glycine and increased NMDA-receptor currents.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Mouse genetic deletion with extracellular amino-acid measurements and electrophysiology.
- limitations
- This does not show that oral proline treats NMDAR dysfunction in humans. Correction record: Author correction PMID 39242973 / DOI 10.1038/s44321-024-00125-y corrects the human embryonic stem-cell neuron protocol IRB approval number to KH2017-109 from KA2018-61 and KH2020-55. It does not report a change to experimental results. https://link.springer.com/article/10.1038/s44321-024-00125-y
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- Changing a proline-sharing transporter can change glycine-dependent brain signaling.
- primary_references
- SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33428810/ · DOI 10.15252/emmm.202012632
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 206–212
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse genetic deletion with extracellular amino-acid measurements and electrophysiology. · source_derived_draft · unverified_draft
## l-proline-brain-transporter-loss Changing a proline-sharing transporter can change glycine-dependent brain signaling. Slc6a20a-knockout mice had higher extracellular brain glycine and increased NMDA-receptor currents. Model: Mouse genetic deletion with extracellular amino-acid measurements and electrophysiology. Limitations: This does not show that oral proline treats NMDAR dysfunction in humans. Correction record: Author correction PMID 39242973 / DOI 10.1038/s44321-024-00125-y corrects the human embryonic stem-cell neuron protocol IRB approval number to KH2017-109 from KA2018-61 and KH2020-55. It does not report a change to experimental results. https://link.springer.com/article/10.1038/s44321-024-00125-y Evidence access: Primary full text SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33428810/ · DOI 10.15252/emmm.202012632
Complete structured claim and evidenceHuman SIT1 produced glycine-evoked current about 18% of the proline response in the reported substrate comparison; sarcosine current was about 83%.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human SIT1 in Xenopus oocytes; 1 mM substrates at pH 7.4 and -60 mV.
- limitations
- Failure of glycine to stabilize purified SIT1 thermally did not rule out its transport; binding-proxy and transport assays measure different things.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- This transporter has overlapping amino-acid routes with unequal efficiency.
- primary_references
- Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38951531/ · DOI 10.1038/s41467-024-48921-x
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 190–196
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human SIT1 in Xenopus oocytes; 1 mM substrates at pH 7.4 and -60 mV. · source_derived_draft · unverified_draft
## l-proline-sit1-glycine This transporter has overlapping amino-acid routes with unequal efficiency. Human SIT1 produced glycine-evoked current about 18% of the proline response in the reported substrate comparison; sarcosine current was about 83%. Model: Human SIT1 in Xenopus oocytes; 1 mM substrates at pH 7.4 and -60 mV. Limitations: Failure of glycine to stabilize purified SIT1 thermally did not rule out its transport; binding-proxy and transport assays measure different things. Evidence access: Primary full text Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38951531/ · DOI 10.1038/s41467-024-48921-x
Complete structured claim and evidenceA study in six adult men detected limited threonine-derived glycine labeling, accounting for an estimated 7–11% of threonine catabolism under its model.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Four-hour labeled-threonine/glycine infusions under control and high-threonine diets.
- limitations
- The paper called this TDG flux before the human TDH pseudogene was characterized. Retain the tracer observation without asserting functional human TDH; alternative routes were not resolved.
- nutrient_topic
- L-Threonine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Threonine
- plain_language
- Detecting carbon transfer does not identify the enzyme responsible.
- primary_references
- Threonine dehydrogenase is a minor degradative pathway of threonine catabolism in adult humans. · 2000 · https://pubmed.ncbi.nlm.nih.gov/10780944/ · DOI 10.1152/ajpendo.2000.278.5.E877
L-Threonine: translation, intestinal barrier, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 290–296
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Four-hour labeled-threonine/glycine infusions under control and high-threonine diets. · source_derived_draft · unverified_draft
## l-threonine-human-glycine-tracer Detecting carbon transfer does not identify the enzyme responsible. A study in six adult men detected limited threonine-derived glycine labeling, accounting for an estimated 7–11% of threonine catabolism under its model. Model: Four-hour labeled-threonine/glycine infusions under control and high-threonine diets. Limitations: The paper called this TDG flux before the human TDH pseudogene was characterized. Retain the tracer observation without asserting functional human TDH; alternative routes were not resolved. Evidence access: Primary abstract Threonine dehydrogenase is a minor degradative pathway of threonine catabolism in adult humans. · 2000 · https://pubmed.ncbi.nlm.nih.gov/10780944/ · DOI 10.1152/ajpendo.2000.278.5.E877
Complete structured claim and evidence
Where it participates (unsigned role)
An ACADSB splice defect caused exon skipping, impaired 2-methylbutyryl-CoA oxidation and isolated 2-methylbutyrylglycinuria in the reported patient.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human patient fibroblast assays plus expression validation.
- limitations
- Single-patient mechanistic discovery does not determine severity for all screen-detected variants.
- nutrient_topic
- L-Isoleucine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Isoleucine
- plain_language
- A breakdown block can be detected through an alternative excreted product.
- primary_references
- Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11013134/ · DOI 10.1086/303105
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Isoleucine: transport, translation, catabolism and cross-nutrient mechanisms (2026-09-19) · lines 186–192
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human patient fibroblast assays plus expression validation. · source_derived_draft · unverified_draft
## isoleucine-acadsb-loss A breakdown block can be detected through an alternative excreted product. An ACADSB splice defect caused exon skipping, impaired 2-methylbutyryl-CoA oxidation and isolated 2-methylbutyrylglycinuria in the reported patient. Model: Human patient fibroblast assays plus expression validation. Limitations: Single-patient mechanistic discovery does not determine severity for all screen-detected variants. Evidence access: Primary abstract Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11013134/ · DOI 10.1086/303105
Complete structured claim and evidencePre-steady-state analysis of human AGXT showed that PMP remained bound during its catalytic cycle and the AGXT–PMP complex reacted efficiently with oxo-acid substrates.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Purified human AGXT; PLP-form reactions with alanine/glycine and PMP-form reactions with pyruvate/glyoxylate.
- limitations
- Cofactor cycling is not evidence that B6 is irreversibly consumed once per reaction.
- nutrient_topic
- L-Alanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Alanine
- plain_language
- The B6 cofactor changes form while helping transfer nitrogen.
- primary_references
- Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17696873/ · DOI 10.1042/BJ20070637
L-Alanine: carbon, nitrogen, protein synthesis and cross-nutrient mechanisms (2026-09-19) · lines 40–46
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human AGXT; PLP-form reactions with alanine/glycine and PMP-form reactions with pyruvate/glyoxylate. · source_derived_draft · unverified_draft
## alanine-agt-pmp-cycle The B6 cofactor changes form while helping transfer nitrogen. Pre-steady-state analysis of human AGXT showed that PMP remained bound during its catalytic cycle and the AGXT–PMP complex reacted efficiently with oxo-acid substrates. Model: Purified human AGXT; PLP-form reactions with alanine/glycine and PMP-form reactions with pyruvate/glyoxylate. Limitations: Cofactor cycling is not evidence that B6 is irreversibly consumed once per reaction. Evidence access: Primary abstract Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17696873/ · DOI 10.1042/BJ20070637
Complete structured claim and evidencePurified untagged human AGXT catalyzed the PLP-dependent reaction alanine + glyoxylate ⇌ pyruvate + glycine; forward and reverse kinetic parameters were measured.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Recombinant human liver enzyme expressed in E. coli; kinetic and cofactor-binding assays.
- limitations
- Peroxisomal enzyme identity does not mean intracellular flux or supplement benefit was measured.
- nutrient_topic
- L-Alanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Alanine
- plain_language
- Alanine supplies an amino group that turns glyoxylate into glycine.
- primary_references
- Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18289107/ · DOI 10.2174/092986608783489580
L-Alanine: carbon, nitrogen, protein synthesis and cross-nutrient mechanisms (2026-09-19) · lines 32–38
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human liver enzyme expressed in E. coli; kinetic and cofactor-binding assays. · source_derived_draft · unverified_draft
## alanine-agt-reaction Alanine supplies an amino group that turns glyoxylate into glycine. Purified untagged human AGXT catalyzed the PLP-dependent reaction alanine + glyoxylate ⇌ pyruvate + glycine; forward and reverse kinetic parameters were measured. Model: Recombinant human liver enzyme expressed in E. coli; kinetic and cofactor-binding assays. Limitations: Peroxisomal enzyme identity does not mean intracellular flux or supplement benefit was measured. Evidence access: Primary abstract Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18289107/ · DOI 10.2174/092986608783489580
Complete structured claim and evidenceTargeting mitochondrial pyruvate transport promoted alanine oxidation, reduced deoxysphingolipid production and restored growth under serine/glycine-restricted conditions.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Colorectal cancer model metabolic interventions and tracing.
- limitations
- Context-specific rerouting; it does not establish a universal protective effect of MPC inhibition.
- nutrient_topic
- L-Alanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Alanine
- plain_language
- Changing use of alanine in mitochondria changed its availability to another pathway.
- primary_references
- Serine restriction alters sphingolipid diversity to constrain tumour growth. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32788725/ · DOI 10.1038/s41586-020-2609-x
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Alanine: carbon, nitrogen, protein synthesis and cross-nutrient mechanisms (2026-09-19) · lines 464–470
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Colorectal cancer model metabolic interventions and tracing. · source_derived_draft · unverified_draft
## alanine-serine-mpc-interaction Changing use of alanine in mitochondria changed its availability to another pathway. Targeting mitochondrial pyruvate transport promoted alanine oxidation, reduced deoxysphingolipid production and restored growth under serine/glycine-restricted conditions. Model: Colorectal cancer model metabolic interventions and tracing. Limitations: Context-specific rerouting; it does not establish a universal protective effect of MPC inhibition. Evidence access: Primary full text Serine restriction alters sphingolipid diversity to constrain tumour growth. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32788725/ · DOI 10.1038/s41586-020-2609-x
Complete structured claim and evidenceSerine/glycine restriction increased alanine-derived deoxysphingolipid synthesis in the tested colorectal cancer models and constrained growth.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human colorectal cancer cultures/spheroids with nutrient restriction and isotope tracing; accompanying mouse xenografts.
- limitations
- Cancer nutrient-restriction experiments are not a recommendation to restrict serine or glycine.
- nutrient_topic
- L-Alanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Alanine
- plain_language
- The ratio of available substrates can redirect a shared enzyme even without the inherited neuropathy setting.
- primary_references
- Serine restriction alters sphingolipid diversity to constrain tumour growth. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32788725/ · DOI 10.1038/s41586-020-2609-x
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Alanine: carbon, nitrogen, protein synthesis and cross-nutrient mechanisms (2026-09-19) · lines 456–462
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human colorectal cancer cultures/spheroids with nutrient restriction and isotope tracing; accompanying mouse xenografts. · source_derived_draft · unverified_draft
## alanine-serine-restriction-lipids The ratio of available substrates can redirect a shared enzyme even without the inherited neuropathy setting. Serine/glycine restriction increased alanine-derived deoxysphingolipid synthesis in the tested colorectal cancer models and constrained growth. Model: Human colorectal cancer cultures/spheroids with nutrient restriction and isotope tracing; accompanying mouse xenografts. Limitations: Cancer nutrient-restriction experiments are not a recommendation to restrict serine or glycine. Evidence access: Primary full text Serine restriction alters sphingolipid diversity to constrain tumour growth. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32788725/ · DOI 10.1038/s41586-020-2609-x
Complete structured claim and evidenceRestriction did not significantly change glycine cleavage or serine synthesis from GCS-derived one-carbon units.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- B6-dependent glycine cleavage supplies folate one-carbon chemistry.
- experimental_model
- Thirteen healthy adults (seven men, six women; ages 20–39); glycine and leucine stable-isotope infusion.
- exposure
- Moderate dietary B6 restriction; plasma PLP55±4 to 23±1 nmol/L.
- limitations
- Whole-body kinetics do not resolve separate organs or prove severe deficiency harmless.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Homo sapiens
- plain_language
- This folate-linked carbon supply remained measurable despite lower blood B6.
- primary_references
- [b6-lamers2009] Moderate dietary vitamin B-6 restriction raises plasma glycine and cystathionine concentrations while minimally affecting the rates of glycine turnover and glycine cleavage in healthy men and women (2009). https://pubmed.ncbi.nlm.nih.gov/19158217/ DOI: 10.3945/jn.108.099184
- tissue_or_cell_type
- Human blood and whole-body measurements
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1397–1408
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Thirteen healthy adults (seven men, six women; ages 20–39); glycine and leucine stable-isotope infusion. · source_derived_draft · unverified_draft
### b6-glycine-cleavage-resilience Restriction did not significantly change glycine cleavage or serine synthesis from GCS-derived one-carbon units. Condition category: nutrient_deficiency nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: This folate-linked carbon supply remained measurable despite lower blood B6. organism: Homo sapiens tissue_or_cell_type: Human blood and whole-body measurements experimental_model: Thirteen healthy adults (seven men, six women; ages 20–39); glycine and leucine stable-isotope infusion. limitations: Whole-body kinetics do not resolve separate organs or prove severe deficiency harmless. exposure: Moderate dietary B6 restriction; plasma PLP55±4 to 23±1 nmol/L. cross_nutrient: B6-dependent glycine cleavage supplies folate one-carbon chemistry. [b6-lamers2009] Moderate dietary vitamin B-6 restriction raises plasma glycine and cystathionine concentrations while minimally affecting the rates of glycine turnover and glycine cleavage in healthy men and women (2009). https://pubmed.ncbi.nlm.nih.gov/19158217/ DOI: 10.3945/jn.108.099184
Complete structured claim and evidenceSHMT-mediated glycine-to-serine conversion increased 182 to 205 micromol/kg/hour during restriction, accompanied by higher plasma glycine.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- B6 and folate participate in a reversible reaction; flux direction matters.
- experimental_model
- Thirteen healthy adults (seven men, six women; ages 20–39); glycine and leucine stable-isotope infusion.
- exposure
- Moderate dietary B6 restriction; plasma PLP55±4 to 23±1 nmol/L.
- limitations
- Do not substitute the reverse serine-to-glycine direction or identify the responsible SHMT compartment from whole-body data.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Homo sapiens
- plain_language
- The measured direction ran faster, rather than shutting down.
- primary_references
- [b6-lamers2009] Moderate dietary vitamin B-6 restriction raises plasma glycine and cystathionine concentrations while minimally affecting the rates of glycine turnover and glycine cleavage in healthy men and women (2009). https://pubmed.ncbi.nlm.nih.gov/19158217/ DOI: 10.3945/jn.108.099184
- tissue_or_cell_type
- Human blood and whole-body measurements
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1410–1421
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Thirteen healthy adults (seven men, six women; ages 20–39); glycine and leucine stable-isotope infusion. · source_derived_draft · unverified_draft
### b6-glycine-serine-flux-increase SHMT-mediated glycine-to-serine conversion increased 182 to 205 micromol/kg/hour during restriction, accompanied by higher plasma glycine. Condition category: nutrient_deficiency nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The measured direction ran faster, rather than shutting down. organism: Homo sapiens tissue_or_cell_type: Human blood and whole-body measurements experimental_model: Thirteen healthy adults (seven men, six women; ages 20–39); glycine and leucine stable-isotope infusion. limitations: Do not substitute the reverse serine-to-glycine direction or identify the responsible SHMT compartment from whole-body data. exposure: Moderate dietary B6 restriction; plasma PLP55±4 to 23±1 nmol/L. cross_nutrient: B6 and folate participate in a reversible reaction; flux direction matters. [b6-lamers2009] Moderate dietary vitamin B-6 restriction raises plasma glycine and cystathionine concentrations while minimally affecting the rates of glycine turnover and glycine cleavage in healthy men and women (2009). https://pubmed.ncbi.nlm.nih.gov/19158217/ DOI: 10.3945/jn.108.099184
Complete structured claim and evidenceHuman ALAS2 uses PLP to condense glycine and succinyl-CoA into 5-aminolevulinate, releasing CoA and carbon dioxide.
Experimental context and source evidence
- cross_nutrient
- B6 and glycine support the porphyrin precursor pathway upstream of iron insertion.
- experimental_model
- Purified recombinant human ALAS2; crystallography and kinetics
- limitations
- Iron insertion is a later ferrochelatase reaction, not an ALAS2 reaction.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Homo sapiens
- plain_language
- This B6-dependent step starts erythroid heme synthesis.
- primary_references
- [b6-alas2-2020] Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release (2020). https://www.nature.com/articles/s41467-020-16586-x DOI: 10.1038/s41467-020-16586-x
- tissue_or_cell_type
- Purified recombinant protein; no intact tissue
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 799–809
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified recombinant human ALAS2; crystallography and kinetics · source_derived_draft · unverified_draft
### b6-met-alas2-ala Human ALAS2 uses PLP to condense glycine and succinyl-CoA into 5-aminolevulinate, releasing CoA and carbon dioxide. Condition category: normal nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: This B6-dependent step starts erythroid heme synthesis. organism: Homo sapiens tissue_or_cell_type: Purified recombinant protein; no intact tissue experimental_model: Purified recombinant human ALAS2; crystallography and kinetics limitations: Iron insertion is a later ferrochelatase reaction, not an ALAS2 reaction. cross_nutrient: B6 and glycine support the porphyrin precursor pathway upstream of iron insertion. [b6-alas2-2020] Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release (2020). https://www.nature.com/articles/s41467-020-16586-x DOI: 10.1038/s41467-020-16586-x
Complete structured claim and evidenceHuman SHMT1 uses PLP to couple serine-to-glycine conversion with transfer of a one-carbon unit to tetrahydrofolate.
Experimental context and source evidence
- cross_nutrient
- PLP (B6) and THF (folate) cooperate in one reaction.
- experimental_model
- Purified human SHMT1 and SHMT2; structures and solution oligomerization
- limitations
- Reaction is reversible; assembly assays do not establish flux in every cell.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Homo sapiens
- plain_language
- The enzyme connects B6-dependent amino-acid chemistry to folate chemistry.
- primary_references
- [b6-shmt-2015] How pyridoxal 5'-phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state (2015). https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.13211 DOI: 10.1111/febs.13211
- tissue_or_cell_type
- Purified recombinant protein; no intact tissue
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 602–612
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human SHMT1 and SHMT2; structures and solution oligomerization · source_derived_draft · unverified_draft
### b6-met-shmt1-onecarbon Human SHMT1 uses PLP to couple serine-to-glycine conversion with transfer of a one-carbon unit to tetrahydrofolate. Condition category: normal nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The enzyme connects B6-dependent amino-acid chemistry to folate chemistry. organism: Homo sapiens tissue_or_cell_type: Purified recombinant protein; no intact tissue experimental_model: Purified human SHMT1 and SHMT2; structures and solution oligomerization limitations: Reaction is reversible; assembly assays do not establish flux in every cell. cross_nutrient: PLP (B6) and THF (folate) cooperate in one reaction. [b6-shmt-2015] How pyridoxal 5'-phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state (2015). https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.13211 DOI: 10.1111/febs.13211
Complete structured claim and evidenceHuman SHMT2 uses PLP to couple serine-to-glycine conversion with transfer of a one-carbon unit to tetrahydrofolate.
Experimental context and source evidence
- cross_nutrient
- PLP (B6) and THF (folate) cooperate in one reaction.
- experimental_model
- Purified human SHMT1 and SHMT2; structures and solution oligomerization
- limitations
- Reaction is reversible; assembly assays do not establish flux in every cell.
- nutrient_topic
- Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
- organism
- Homo sapiens
- plain_language
- The enzyme connects B6-dependent amino-acid chemistry to folate chemistry.
- primary_references
- [b6-shmt-2015] How pyridoxal 5'-phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state (2015). https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.13211 DOI: 10.1111/febs.13211
- tissue_or_cell_type
- Purified recombinant protein; no intact tissue
Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 614–624
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human SHMT1 and SHMT2; structures and solution oligomerization · source_derived_draft · unverified_draft
### b6-met-shmt2-onecarbon Human SHMT2 uses PLP to couple serine-to-glycine conversion with transfer of a one-carbon unit to tetrahydrofolate. Condition category: normal nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The enzyme connects B6-dependent amino-acid chemistry to folate chemistry. organism: Homo sapiens tissue_or_cell_type: Purified recombinant protein; no intact tissue experimental_model: Purified human SHMT1 and SHMT2; structures and solution oligomerization limitations: Reaction is reversible; assembly assays do not establish flux in every cell. cross_nutrient: PLP (B6) and THF (folate) cooperate in one reaction. [b6-shmt-2015] How pyridoxal 5'-phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state (2015). https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.13211 DOI: 10.1111/febs.13211
Complete structured claim and evidenceThe same expressed human BAAT also catalyzed glycine conjugation of cholic acid.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Recombinant human enzyme.
- limitations
- Shared enzyme use does not establish clinical competition or a need to balance glycine and taurine supplements.
- nutrient_topic
- Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
- plain_language
- Glycine and taurine converge on the same bile-conjugating enzyme.
- primary_references
- Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. · 1994 · https://pubmed.ncbi.nlm.nih.gov/8034703/
Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 305–311
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human enzyme. · source_derived_draft · unverified_draft
## taurine-baat-glycine Glycine and taurine converge on the same bile-conjugating enzyme. The same expressed human BAAT also catalyzed glycine conjugation of cholic acid. Model: Recombinant human enzyme. Limitations: Shared enzyme use does not establish clinical competition or a need to balance glycine and taurine supplements. Evidence access: Primary abstract Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. · 1994 · https://pubmed.ncbi.nlm.nih.gov/8034703/
Complete structured claim and evidencePatients with defective bile acid amidation lacked glycine and taurine conjugates in urine, bile and serum; four homozygous BAAT mutations were identified among eight tested patients.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Ten pediatric patients; bile chemistry and genetic investigation.
- limitations
- Not evidence that isolated dietary taurine shortage causes the same phenotype.
- nutrient_topic
- Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
- plain_language
- A broken conjugation enzyme affects both amino-acid routes.
- primary_references
- Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23415802/ · DOI 10.1053/j.gastro.2013.02.004
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 313–319
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Ten pediatric patients; bile chemistry and genetic investigation. · source_derived_draft · unverified_draft
## taurine-baat-loss A broken conjugation enzyme affects both amino-acid routes. Patients with defective bile acid amidation lacked glycine and taurine conjugates in urine, bile and serum; four homozygous BAAT mutations were identified among eight tested patients. Model: Ten pediatric patients; bile chemistry and genetic investigation. Limitations: Not evidence that isolated dietary taurine shortage causes the same phenotype. Evidence access: Primary abstract Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23415802/ · DOI 10.1053/j.gastro.2013.02.004
Complete structured claim and evidenceApplied taurine activated recombinant human alpha1 homomeric glycine receptors in oocytes and HEK293 cells; its potency and efficacy varied with the experimental receptor response.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human receptor expressed in Xenopus oocytes or human cells; electrophysiology.
- limitations
- Not a clinical sedative effect; chloride gradient and receptor composition shape cellular response.
- nutrient_topic
- Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
- plain_language
- Taurine can activate a receptor named for glycine.
- primary_references
- Activation of human alpha1 and alpha2 homomeric glycine receptors by taurine and GABA. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11559772/ · DOI 10.1111/j.1469-7793.2001.t01-1-00741.x
Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 417–423
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human receptor expressed in Xenopus oocytes or human cells; electrophysiology. · source_derived_draft · unverified_draft
## taurine-glycine-receptor-alpha1 Taurine can activate a receptor named for glycine. Applied taurine activated recombinant human alpha1 homomeric glycine receptors in oocytes and HEK293 cells; its potency and efficacy varied with the experimental receptor response. Model: Human receptor expressed in Xenopus oocytes or human cells; electrophysiology. Limitations: Not a clinical sedative effect; chloride gradient and receptor composition shape cellular response. Evidence access: Primary abstract Activation of human alpha1 and alpha2 homomeric glycine receptors by taurine and GABA. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11559772/ · DOI 10.1111/j.1469-7793.2001.t01-1-00741.x
Complete structured claim and evidenceApplied taurine also activated human alpha2 homomeric glycine receptors, with efficacy varying from weak to full agonism across tested conditions.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Recombinant human alpha2 receptor electrophysiology.
- limitations
- Avoid labeling taurine a universally weak or full agonist.
- nutrient_topic
- Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
- plain_language
- The receptor subtype and cell setting change the strength of taurine signaling.
- primary_references
- Activation of human alpha1 and alpha2 homomeric glycine receptors by taurine and GABA. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11559772/ · DOI 10.1111/j.1469-7793.2001.t01-1-00741.x
Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 425–431
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human alpha2 receptor electrophysiology. · source_derived_draft · unverified_draft
## taurine-glycine-receptor-alpha2 The receptor subtype and cell setting change the strength of taurine signaling. Applied taurine also activated human alpha2 homomeric glycine receptors, with efficacy varying from weak to full agonism across tested conditions. Model: Recombinant human alpha2 receptor electrophysiology. Limitations: Avoid labeling taurine a universally weak or full agonist. Evidence access: Primary abstract Activation of human alpha1 and alpha2 homomeric glycine receptors by taurine and GABA. · 2001 · https://pubmed.ncbi.nlm.nih.gov/11559772/ · DOI 10.1111/j.1469-7793.2001.t01-1-00741.x
Complete structured claim and evidenceA cinnamic-acid glycine conjugate appeared in substantial amounts only in mice in the rat/mouse comparison.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ceylon-research/7959441.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5bab6bd0ad082e4064c601368d147bfcd87566a98ba749a37974fb1057e8c1be", "start_char": 0, "end_char": 1564, "text_sha256": "5bab6bd0ad082e4064c601368d147bfcd87566a98ba749a37974fb1057e8c1be"}
- experimental_model
- Radiolabeled disposition experiment
- exposure
- 2 or 250 mg/kg intraperitoneal, with an additional 250 mg/kg oral arm
- limitations
- High experimental exposures and rodent species; metabolite recovery does not quantify human nutrient demand or identify every enzyme.
- nutrient_topic
- Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. · Ceylon cinnamon / Cinnamomum verum bark preparations
- organism
- Rats and mice
- plain_language
- The two rodent species did not handle every conjugation pathway identically.
- primary_references
- [ceylon-p7959441] Studies on trans-cinnamaldehyde. 1. The influence of dose size and sex on its disposition in the rat and mouse. (1994). https://pubmed.ncbi.nlm.nih.gov/7959441/ DOI: 10.1016/0278-6915(94)90084-1
- tissue_or_cell_type
- Urine and excreta
Ceylon cinnamon: metabolism, signaling and nutrient connections (2026-09-17) · lines 233–244
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiolabeled disposition experiment · source_derived_draft · unverified_draft
### ceylon-cinnamoylglycine A cinnamic-acid glycine conjugate appeared in substantial amounts only in mice in the rat/mouse comparison. Condition category: normal nutrient_topic: Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. plain_language: The two rodent species did not handle every conjugation pathway identically. organism: Rats and mice tissue_or_cell_type: Urine and excreta experimental_model: Radiolabeled disposition experiment limitations: High experimental exposures and rodent species; metabolite recovery does not quantify human nutrient demand or identify every enzyme. exposure: 2 or 250 mg/kg intraperitoneal, with an additional 250 mg/kg oral arm evidence_span: {"source_cache": "artifacts/ceylon-research/7959441.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5bab6bd0ad082e4064c601368d147bfcd87566a98ba749a37974fb1057e8c1be", "start_char": 0, "end_char": 1564, "text_sha256": "5bab6bd0ad082e4064c601368d147bfcd87566a98ba749a37974fb1057e8c1be"} [ceylon-p7959441] Studies on trans-cinnamaldehyde. 1. The influence of dose size and sex on its disposition in the rat and mouse. (1994). https://pubmed.ncbi.nlm.nih.gov/7959441/ DOI: 10.1016/0278-6915(94)90084-1
Complete structured claim and evidenceHippuric acid was the major urinary metabolite after radiolabeled trans-cinnamaldehyde administration in rats and mice.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ceylon-research/7959441.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5bab6bd0ad082e4064c601368d147bfcd87566a98ba749a37974fb1057e8c1be", "start_char": 0, "end_char": 1564, "text_sha256": "5bab6bd0ad082e4064c601368d147bfcd87566a98ba749a37974fb1057e8c1be"}
- experimental_model
- Radiolabeled disposition experiment
- exposure
- 2 or 250 mg/kg intraperitoneal, with an additional 250 mg/kg oral arm
- limitations
- High experimental exposures and rodent species; metabolite recovery does not quantify human nutrient demand or identify every enzyme.
- nutrient_topic
- Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. · Ceylon cinnamon / Cinnamomum verum bark preparations
- organism
- Rats and mice
- plain_language
- Much of the measured rodent dose left as hippurate, a benzoate-glycine conjugate.
- primary_references
- [ceylon-p7959441] Studies on trans-cinnamaldehyde. 1. The influence of dose size and sex on its disposition in the rat and mouse. (1994). https://pubmed.ncbi.nlm.nih.gov/7959441/ DOI: 10.1016/0278-6915(94)90084-1
- tissue_or_cell_type
- Urine and excreta
Ceylon cinnamon: metabolism, signaling and nutrient connections (2026-09-17) · lines 194–205
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiolabeled disposition experiment · source_derived_draft · unverified_draft
### ceylon-hippurate Hippuric acid was the major urinary metabolite after radiolabeled trans-cinnamaldehyde administration in rats and mice. Condition category: normal nutrient_topic: Ceylon cinnamon research collection; topical membership is not evidence of a direct dietary effect. plain_language: Much of the measured rodent dose left as hippurate, a benzoate-glycine conjugate. organism: Rats and mice tissue_or_cell_type: Urine and excreta experimental_model: Radiolabeled disposition experiment limitations: High experimental exposures and rodent species; metabolite recovery does not quantify human nutrient demand or identify every enzyme. exposure: 2 or 250 mg/kg intraperitoneal, with an additional 250 mg/kg oral arm evidence_span: {"source_cache": "artifacts/ceylon-research/7959441.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5bab6bd0ad082e4064c601368d147bfcd87566a98ba749a37974fb1057e8c1be", "start_char": 0, "end_char": 1564, "text_sha256": "5bab6bd0ad082e4064c601368d147bfcd87566a98ba749a37974fb1057e8c1be"} [ceylon-p7959441] Studies on trans-cinnamaldehyde. 1. The influence of dose size and sex on its disposition in the rat and mouse. (1994). https://pubmed.ncbi.nlm.nih.gov/7959441/ DOI: 10.1016/0278-6915(94)90084-1
Complete structured claim and evidenceRat GNMT structures located two folate-binding sites between subunits; occupancy restricts the N-terminal movements needed for substrate access.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat liver GNMT crystallography and binding experiments.
- limitations
- Rat enzyme and defined ligand conditions; not a demonstrated human supplement interaction.
- nutrient_topic
- L-Methionine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Methionine
- plain_language
- Folate can regulate methyl-group disposal through glycine.
- primary_references
- 5-methyltetrahydrofolate is bound in intersubunit areas of rat liver folate-binding protein glycine N-methyltransferase. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17158459/ · DOI 10.1074/jbc.M610384200
L-Methionine: transport, methylation, sulfur metabolism and cross-nutrient mechanisms (2026-09-19) · lines 212–218
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat liver GNMT crystallography and binding experiments. · source_derived_draft · unverified_draft
## methionine-gnmt-folate-structure Folate can regulate methyl-group disposal through glycine. Rat GNMT structures located two folate-binding sites between subunits; occupancy restricts the N-terminal movements needed for substrate access. Model: Rat liver GNMT crystallography and binding experiments. Limitations: Rat enzyme and defined ligand conditions; not a demonstrated human supplement interaction. Evidence access: Primary abstract 5-methyltetrahydrofolate is bound in intersubunit areas of rat liver folate-binding protein glycine N-methyltransferase. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17158459/ · DOI 10.1074/jbc.M610384200
Complete structured claim and evidenceAGAT catalyzes transfer of an amidino group from arginine to glycine, forming guanidinoacetate and ornithine.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/creatine-research/9218780.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "407baedc2f982a5abb9d14a01e8ac9dc331d60115acc716604c1e6003aa12c1b", "start_char": 0, "end_char": 1112, "text_sha256": "407baedc2f982a5abb9d14a01e8ac9dc331d60115acc716604c1e6003aa12c1b"}
- experimental_model
- Human AGAT crystal structures and inactive-mutant substrate complex
- exposure
- Native, ornithine-bound and inactive mutant structures
- limitations
- Structures support an amidino-transfer mechanism; substrate availability in a person and effects of amino-acid supplementation were not measured.
- nutrient_topic
- Creatine research collection; topical membership is not evidence of a direct dietary effect. · Creatine
- organism
- Recombinant human enzyme
- plain_language
- The first synthesis step joins material from arginine and glycine to make the precursor of creatine.
- primary_references
- [creatine-p9218780] Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis. (1997). https://pubmed.ncbi.nlm.nih.gov/9218780/ DOI: 10.1093/emboj/16.12.3373
- tissue_or_cell_type
- Purified protein
Creatine: synthesis, transport, phosphocreatine energetics and nutrient interactions (2026-09-17) · lines 177–188
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human AGAT crystal structures and inactive-mutant substrate complex · source_derived_draft · unverified_draft
### creatine-agat-reaction AGAT catalyzes transfer of an amidino group from arginine to glycine, forming guanidinoacetate and ornithine. Condition category: normal nutrient_topic: Creatine research collection; topical membership is not evidence of a direct dietary effect. plain_language: The first synthesis step joins material from arginine and glycine to make the precursor of creatine. organism: Recombinant human enzyme tissue_or_cell_type: Purified protein experimental_model: Human AGAT crystal structures and inactive-mutant substrate complex limitations: Structures support an amidino-transfer mechanism; substrate availability in a person and effects of amino-acid supplementation were not measured. exposure: Native, ornithine-bound and inactive mutant structures evidence_span: {"source_cache": "artifacts/creatine-research/9218780.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "407baedc2f982a5abb9d14a01e8ac9dc331d60115acc716604c1e6003aa12c1b", "start_char": 0, "end_char": 1112, "text_sha256": "407baedc2f982a5abb9d14a01e8ac9dc331d60115acc716604c1e6003aa12c1b"} [creatine-p9218780] Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis. (1997). https://pubmed.ncbi.nlm.nih.gov/9218780/ DOI: 10.1093/emboj/16.12.3373
Complete structured claim and evidenceHuman GSS joins gamma-glutamylcysteine and glycine in an ATP-dependent reaction to form glutathione.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/30581542.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "77cf6674cf9b9bc140a228588a53c937966fd3a67397c1c4970221c5cc58a0b1", "start_char": 923, "end_char": 1092, "text_sha256": "bed9ef1323b513b1e31b65277f28b935ddf0c9b0c83cbe9ee9f827f97806846c"}
- experimental_model
- Human enzyme mutagenesis, kinetics and molecular dynamics
- exposure
- S-loop variants; established biosynthetic reactions described in the introduction
- limitations
- Reaction descriptions are background chemistry in a primary enzyme paper, not evidence that sulforaphane corrects inherited GSS deficiency.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human GSS
- plain_language
- A second enzyme, glycine and energy complete the molecule.
- primary_references
- [sulforaphane-p30581542] Genetic Mutations in the S-loop of Human Glutathione Synthetase: Links Between Substrate Binding, Active Site Structure and Allostery. (2019). https://pubmed.ncbi.nlm.nih.gov/30581542/ DOI: 10.1016/j.csbj.2018.11.008
- tissue_or_cell_type
- Glutathione synthesis and substrate binding
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 853–864
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human enzyme mutagenesis, kinetics and molecular dynamics · source_derived_draft · unverified_draft
### sulforaphane-gss-second-step Human GSS joins gamma-glutamylcysteine and glycine in an ATP-dependent reaction to form glutathione. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: A second enzyme, glycine and energy complete the molecule. organism: Human GSS tissue_or_cell_type: Glutathione synthesis and substrate binding experimental_model: Human enzyme mutagenesis, kinetics and molecular dynamics limitations: Reaction descriptions are background chemistry in a primary enzyme paper, not evidence that sulforaphane corrects inherited GSS deficiency. exposure: S-loop variants; established biosynthetic reactions described in the introduction evidence_span: {"source_cache": "artifacts/sulforaphane-research/30581542.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "77cf6674cf9b9bc140a228588a53c937966fd3a67397c1c4970221c5cc58a0b1", "start_char": 923, "end_char": 1092, "text_sha256": "bed9ef1323b513b1e31b65277f28b935ddf0c9b0c83cbe9ee9f827f97806846c"} [sulforaphane-p30581542] Genetic Mutations in the S-loop of Human Glutathione Synthetase: Links Between Substrate Binding, Active Site Structure and Allostery. (2019). https://pubmed.ncbi.nlm.nih.gov/30581542/ DOI: 10.1016/j.csbj.2018.11.008
Complete structured claim and evidenceDuring sodium-benzoate treatment of five neonatal-onset nonketotic-hyperglycinemia patients, three of four tested had plasma carnitine deficiency and benzoylcarnitine was detected.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Small treated human case series.
- limitations
- No untreated comparator; association does not quantify an ordinary food-preservative effect.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Using one conjugation route can be accompanied by loss of another nutrient.
- primary_references
- Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia. · 1995 · https://pubmed.ncbi.nlm.nih.gov/8585564/ · DOI 10.1002/ajmg.1320590410
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 314–320
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Small treated human case series. · source_derived_draft · unverified_draft
## glycine-benzoate-carnitine Using one conjugation route can be accompanied by loss of another nutrient. During sodium-benzoate treatment of five neonatal-onset nonketotic-hyperglycinemia patients, three of four tested had plasma carnitine deficiency and benzoylcarnitine was detected. Model: Small treated human case series. Limitations: No untreated comparator; association does not quantify an ordinary food-preservative effect. Evidence access: Primary abstract Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia. · 1995 · https://pubmed.ncbi.nlm.nih.gov/8585564/ · DOI 10.1002/ajmg.1320590410
Complete structured claim and evidenceL-carnitine treatment normalized plasma free carnitine in the reported benzoate-treated patients; increased glycine conjugation was a tendency rather than a definitive outcome.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human nonketotic-hyperglycinemia case series.
- limitations
- Do not infer a general glycine/carnitine supplement combination or a dosing recommendation.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A measured treatment-associated nutrient deficit responded to replacement.
- primary_references
- Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia. · 1995 · https://pubmed.ncbi.nlm.nih.gov/8585564/ · DOI 10.1002/ajmg.1320590410
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 322–328
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human nonketotic-hyperglycinemia case series. · source_derived_draft · unverified_draft
## glycine-benzoate-carnitine-repletion A measured treatment-associated nutrient deficit responded to replacement. L-carnitine treatment normalized plasma free carnitine in the reported benzoate-treated patients; increased glycine conjugation was a tendency rather than a definitive outcome. Model: Human nonketotic-hyperglycinemia case series. Limitations: Do not infer a general glycine/carnitine supplement combination or a dosing recommendation. Evidence access: Primary abstract Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia. · 1995 · https://pubmed.ncbi.nlm.nih.gov/8585564/ · DOI 10.1002/ajmg.1320590410
Complete structured claim and evidenceAdding folate with glycine restored hemoglobin in the tested zebrafish Slc25a38-deficiency model.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Zebrafish supplementation experiment.
- limitations
- Combination rescue is recorded without claiming clinical efficacy or statistical synergy in humans.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A second nutrient changed the response to the first in this model.
- primary_references
- Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia. · 2016 · https://pubmed.ncbi.nlm.nih.gov/26821380/ · DOI 10.1371/journal.pgen.1005783
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 106–112
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Zebrafish supplementation experiment. · source_derived_draft · unverified_draft
## glycine-fish-glycine-folate A second nutrient changed the response to the first in this model. Adding folate with glycine restored hemoglobin in the tested zebrafish Slc25a38-deficiency model. Model: Zebrafish supplementation experiment. Limitations: Combination rescue is recorded without claiming clinical efficacy or statistical synergy in humans. Evidence access: Primary full text Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia. · 2016 · https://pubmed.ncbi.nlm.nih.gov/26821380/ · DOI 10.1371/journal.pgen.1005783
Complete structured claim and evidenceFormate restored nucleotide synthesis and growth in glycine-fed cells lacking serine.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cancer-cell nutrient and formate rescue experiment.
- limitations
- No extrapolation to treating cancer or supplement combinations in people.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Another input changed whether supplied glycine could support growth.
- primary_references
- Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24813884/ · DOI 10.1016/j.celrep.2014.04.045
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 186–192
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cancer-cell nutrient and formate rescue experiment. · source_derived_draft · unverified_draft
## glycine-formate-serine-deprived-rescue Another input changed whether supplied glycine could support growth. Formate restored nucleotide synthesis and growth in glycine-fed cells lacking serine. Model: Cancer-cell nutrient and formate rescue experiment. Limitations: No extrapolation to treating cancer or supplement combinations in people. Evidence access: Primary abstract Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24813884/ · DOI 10.1016/j.celrep.2014.04.045
Complete structured claim and evidenceA patient with compound GARS variants had tissue respiratory-chain deficiencies and reduced GARS/complex-IV protein in fibroblasts.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Single human case with tissue enzyme assays, sequencing and fibroblast immunoblotting.
- limitations
- The authors support a likely causal genotype; a single case is not proof of a universal mechanism or a glycine-replacement response.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A glycine-using translation defect can affect cellular energy systems.
- primary_references
- Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28594869/ · DOI 10.1371/journal.pone.0178125
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 394–400
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Single human case with tissue enzyme assays, sequencing and fibroblast immunoblotting. · source_derived_draft · unverified_draft
## glycine-gars-human-variants A glycine-using translation defect can affect cellular energy systems. A patient with compound GARS variants had tissue respiratory-chain deficiencies and reduced GARS/complex-IV protein in fibroblasts. Model: Single human case with tissue enzyme assays, sequencing and fibroblast immunoblotting. Limitations: The authors support a likely causal genotype; a single case is not proof of a universal mechanism or a glycine-replacement response. Evidence access: Primary full text Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28594869/ · DOI 10.1371/journal.pone.0178125
Complete structured claim and evidenceFormate treatment normalized folate profiles, restored embryonic growth and prevented neural-tube defects in the tested Gldc-deficient mice.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Mouse developmental model and formate supplementation.
- limitations
- Does not establish treatment of human nonketotic hyperglycinemia or prove all disease features are formate-responsive.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A downstream carbon donor bypassed part of the missing pathway.
- primary_references
- Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25736695/ · DOI 10.1038/ncomms7388
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 138–144
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse developmental model and formate supplementation. · source_derived_draft · unverified_draft
## glycine-gldc-formate-bypass A downstream carbon donor bypassed part of the missing pathway. Formate treatment normalized folate profiles, restored embryonic growth and prevented neural-tube defects in the tested Gldc-deficient mice. Model: Mouse developmental model and formate supplementation. Limitations: Does not establish treatment of human nonketotic hyperglycinemia or prove all disease features are formate-responsive. Evidence access: Primary full text Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25736695/ · DOI 10.1038/ncomms7388
Complete structured claim and evidenceReducing Gldc expression in mice suppressed glycine cleavage and depleted one-carbon-bearing folates while glycine accumulated.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Mouse gene-trap model; enzyme activity and tissue metabolites.
- limitations
- Inherited processing failure is distinct from insufficient dietary glycine.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Excess glycine can coexist with a shortage of products made from it.
- primary_references
- Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25736695/ · DOI 10.1038/ncomms7388
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 130–136
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse gene-trap model; enzyme activity and tissue metabolites. · source_derived_draft · unverified_draft
## glycine-gldc-one-carbon-loss Excess glycine can coexist with a shortage of products made from it. Reducing Gldc expression in mice suppressed glycine cleavage and depleted one-carbon-bearing folates while glycine accumulated. Model: Mouse gene-trap model; enzyme activity and tissue metabolites. Limitations: Inherited processing failure is distinct from insufficient dietary glycine. Evidence access: Primary full text Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25736695/ · DOI 10.1038/ncomms7388
Complete structured claim and evidenceRecombinant human GLYAT variants conjugated glycine to benzoyl-CoA in kinetic assays, forming the glycine-conjugation product hippurate.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Purified human GLYAT haplotypes, two-substrate kinetic analysis.
- limitations
- Reaction uses an activated acyl-CoA, not free benzoate; pathway activation and CoA release remain separate steps.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Activated acyl groups can be transferred onto glycine for disposal.
- primary_references
- Functional Characterisation of Three Glycine N-Acyltransferase Variants and the Effect on Glycine Conjugation to Benzoyl-CoA. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33803916/ · DOI 10.3390/ijms22063129
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 274–280
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified human GLYAT haplotypes, two-substrate kinetic analysis. · source_derived_draft · unverified_draft
## glycine-glyat-benzoyl Activated acyl groups can be transferred onto glycine for disposal. Recombinant human GLYAT variants conjugated glycine to benzoyl-CoA in kinetic assays, forming the glycine-conjugation product hippurate. Model: Purified human GLYAT haplotypes, two-substrate kinetic analysis. Limitations: Reaction uses an activated acyl-CoA, not free benzoate; pathway activation and CoA release remain separate steps. Evidence access: Primary full text Functional Characterisation of Three Glycine N-Acyltransferase Variants and the Effect on Glycine Conjugation to Benzoyl-CoA. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33803916/ · DOI 10.3390/ijms22063129
Complete structured claim and evidencePurified GLYAT formed N-isovalerylglycine from isovaleryl-CoA and glycine in vitro, with lower affinity than for its preferred substrate.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Recombinant enzyme validation alongside docking.
- limitations
- The causal evidence recorded here is the enzyme assay, not the docking prediction; whole-body contribution is unresolved.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Glycine conjugation can intersect with leucine-breakdown metabolites.
- primary_references
- The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36817957/ · DOI 10.1016/j.csbj.2023.01.041
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 290–296
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant enzyme validation alongside docking. · source_derived_draft · unverified_draft
## glycine-glyat-isovaleryl Glycine conjugation can intersect with leucine-breakdown metabolites. Purified GLYAT formed N-isovalerylglycine from isovaleryl-CoA and glycine in vitro, with lower affinity than for its preferred substrate. Model: Recombinant enzyme validation alongside docking. Limitations: The causal evidence recorded here is the enzyme assay, not the docking prediction; whole-body contribution is unresolved. Evidence access: Primary full text The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36817957/ · DOI 10.1016/j.csbj.2023.01.041
Complete structured claim and evidenceThe human GLYAT N156S/R199C variant had turnover about 9.8% of the common N156S reference haplotype in vitro despite greater apparent benzoyl-CoA affinity.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Recombinant haplotype kinetics; not a patient treatment trial.
- limitations
- Potential clinical consequences remain untested; do not equate genotype with a known glycine-deficiency syndrome.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Tighter apparent binding did not mean faster detoxification.
- primary_references
- Functional Characterisation of Three Glycine N-Acyltransferase Variants and the Effect on Glycine Conjugation to Benzoyl-CoA. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33803916/ · DOI 10.3390/ijms22063129
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 282–288
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant haplotype kinetics; not a patient treatment trial. · source_derived_draft · unverified_draft
## glycine-glyat-variant Tighter apparent binding did not mean faster detoxification. The human GLYAT N156S/R199C variant had turnover about 9.8% of the common N156S reference haplotype in vitro despite greater apparent benzoyl-CoA affinity. Model: Recombinant haplotype kinetics; not a patient treatment trial. Limitations: Potential clinical consequences remain untested; do not equate genotype with a known glycine-deficiency syndrome. Evidence access: Primary full text Functional Characterisation of Three Glycine N-Acyltransferase Variants and the Effect on Glycine Conjugation to Benzoyl-CoA. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33803916/ · DOI 10.3390/ijms22063129
Complete structured claim and evidencePurified GLYATL1 also supported N-isovalerylglycine formation in vitro, less favorably than its preferred substrate reaction.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Purified enzyme assays.
- limitations
- Does not establish which enzyme dominates in a patient.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A related enzyme provides another possible route to the same product.
- primary_references
- The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36817957/ · DOI 10.1016/j.csbj.2023.01.041
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 298–304
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified enzyme assays. · source_derived_draft · unverified_draft
## glycine-glyatl1-isovaleryl A related enzyme provides another possible route to the same product. Purified GLYATL1 also supported N-isovalerylglycine formation in vitro, less favorably than its preferred substrate reaction. Model: Purified enzyme assays. Limitations: Does not establish which enzyme dominates in a patient. Evidence access: Primary full text The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36817957/ · DOI 10.1016/j.csbj.2023.01.041
Complete structured claim and evidenceRemoving extracellular glycine alone slowed LOX IMVI proliferation but did not impair A498 cells in the same study.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human cancer-cell comparison under culture glycine withdrawal.
- limitations
- A local experimental shortage, not a universal human dietary deficiency threshold.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Some cells depend more on imported glycine than others.
- primary_references
- Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22628656/ · DOI 10.1126/science.1218595
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 162–168
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer-cell comparison under culture glycine withdrawal. · source_derived_draft · unverified_draft
## glycine-glycine-withdrawal Some cells depend more on imported glycine than others. Removing extracellular glycine alone slowed LOX IMVI proliferation but did not impair A498 cells in the same study. Model: Human cancer-cell comparison under culture glycine withdrawal. Limitations: A local experimental shortage, not a universal human dietary deficiency threshold. Evidence access: Primary full text Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22628656/ · DOI 10.1126/science.1218595
Complete structured claim and evidenceHuman alpha1(K276E)/beta receptors expressed in Xenopus oocytes were about 29-fold less glycine-sensitive than wild type and had shorter channel openings.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human disease-associated receptor constructs in frog oocytes; concentration-response and single-channel recording.
- limitations
- Modeling implicated impaired gating rather than simply loss of ligand binding; not dietary glycine deficiency.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The receptor can respond poorly even when its ligand is supplied.
- primary_references
- Properties of human glycine receptors containing the hyperekplexia mutation alpha1(K276E), expressed in Xenopus oocytes. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9490812/ · DOI 10.1111/j.1469-7793.1998.025bu.x
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 210–216
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human disease-associated receptor constructs in frog oocytes; concentration-response and single-channel recording. · source_derived_draft · unverified_draft
## glycine-glyr-variant The receptor can respond poorly even when its ligand is supplied. Human alpha1(K276E)/beta receptors expressed in Xenopus oocytes were about 29-fold less glycine-sensitive than wild type and had shorter channel openings. Model: Human disease-associated receptor constructs in frog oocytes; concentration-response and single-channel recording. Limitations: Modeling implicated impaired gating rather than simply loss of ligand binding; not dietary glycine deficiency. Evidence access: Primary abstract Properties of human glycine receptors containing the hyperekplexia mutation alpha1(K276E), expressed in Xenopus oocytes. · 1998 · https://pubmed.ncbi.nlm.nih.gov/9490812/ · DOI 10.1111/j.1469-7793.1998.025bu.x
Complete structured claim and evidenceGlyT1 and GlyT2 maintained forward transport under the tested elevated intracellular sodium or chloride conditions, consistent with cooperative ion/substrate binding.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human GlyT1/GlyT2 voltage-clamp measurements and kinetic models.
- limitations
- Binding-order models are interpretations constrained by currents, not direct structures of every transport state.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Raising one intracellular ion did not simply switch these transporters off.
- primary_references
- A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31270129/ · DOI 10.1085/jgp.201912318
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 42–48
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human GlyT1/GlyT2 voltage-clamp measurements and kinetic models. · source_derived_draft · unverified_draft
## glycine-glyt-ion-cooperativity Raising one intracellular ion did not simply switch these transporters off. GlyT1 and GlyT2 maintained forward transport under the tested elevated intracellular sodium or chloride conditions, consistent with cooperative ion/substrate binding. Model: Human GlyT1/GlyT2 voltage-clamp measurements and kinetic models. Limitations: Binding-order models are interpretations constrained by currents, not direct structures of every transport state. Evidence access: Primary full text A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2. · 2019 · https://pubmed.ncbi.nlm.nih.gov/31270129/ · DOI 10.1085/jgp.201912318
Complete structured claim and evidenceFour affected individuals from two families had truncating SLC6A9 variants; two tested individuals had mildly elevated CSF glycine with normal serum glycine.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human family sequencing and biochemical phenotyping.
- limitations
- Small rare-disease series; CSF abnormality is not inferred in untested relatives or healthy people.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A normal blood result can miss an abnormal brain-fluid pool.
- primary_references
- Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27773429/ · DOI 10.1016/j.ajhg.2016.09.004
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 58–64
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human family sequencing and biochemical phenotyping. · source_derived_draft · unverified_draft
## glycine-glyt1-human-loss A normal blood result can miss an abnormal brain-fluid pool. Four affected individuals from two families had truncating SLC6A9 variants; two tested individuals had mildly elevated CSF glycine with normal serum glycine. Model: Human family sequencing and biochemical phenotyping. Limitations: Small rare-disease series; CSF abnormality is not inferred in untested relatives or healthy people. Evidence access: Primary abstract Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27773429/ · DOI 10.1016/j.ajhg.2016.09.004
Complete structured claim and evidenceDeleting mouse Slc6a5 reduced glycinergic miniature inhibitory-current amplitudes in hypoglossal motoneurons and dissociated spinal neurons.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Mouse knockout; neuronal electrophysiology and postnatal neuromotor phenotype.
- limitations
- Transporter deletion is not dietary glycine deficiency.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Loss of replenishment machinery weakens inhibitory transmitter output.
- primary_references
- Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. · 2003 · https://pubmed.ncbi.nlm.nih.gov/14622583/ · DOI 10.1016/s0896-6273(03)00673-1
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 50–56
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse knockout; neuronal electrophysiology and postnatal neuromotor phenotype. · source_derived_draft · unverified_draft
## glycine-glyt2-loss Loss of replenishment machinery weakens inhibitory transmitter output. Deleting mouse Slc6a5 reduced glycinergic miniature inhibitory-current amplitudes in hypoglossal motoneurons and dissociated spinal neurons. Model: Mouse knockout; neuronal electrophysiology and postnatal neuromotor phenotype. Limitations: Transporter deletion is not dietary glycine deficiency. Evidence access: Primary abstract Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. · 2003 · https://pubmed.ncbi.nlm.nih.gov/14622583/ · DOI 10.1016/s0896-6273(03)00673-1
Complete structured claim and evidenceAdded glycine reduced cAMP in GPR158-expressing U87 and HEK293 assays; coexpression of RGS7/G-beta5 strengthened the response.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Recombinant expression and cAMP biosensors.
- limitations
- Direction of cAMP regulation is cell-context dependent; do not infer universal cAMP lowering.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A receptor connects glycine to an intracellular messenger.
- primary_references
- Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 234–240
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant expression and cAMP biosensors. · source_derived_draft · unverified_draft
## glycine-gpr158-camp A receptor connects glycine to an intracellular messenger. Added glycine reduced cAMP in GPR158-expressing U87 and HEK293 assays; coexpression of RGS7/G-beta5 strengthened the response. Model: Recombinant expression and cAMP biosensors. Limitations: Direction of cAMP regulation is cell-context dependent; do not infer universal cAMP lowering. Evidence access: Primary full text Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Complete structured claim and evidenceBath glycine at 1 mM increased layer-II/III prefrontal neuronal excitability in control mice but not Gpr158-knockout mice under synaptic receptor blockade.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Mouse acute slices, intrinsic-current measurements and knockout comparison.
- limitations
- High bath exposure; absence of effect in layer V reinforces cell-type specificity.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- This receptor can make selected neurons more excitable.
- primary_references
- Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 250–256
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse acute slices, intrinsic-current measurements and knockout comparison. · source_derived_draft · unverified_draft
## glycine-gpr158-cortex This receptor can make selected neurons more excitable. Bath glycine at 1 mM increased layer-II/III prefrontal neuronal excitability in control mice but not Gpr158-knockout mice under synaptic receptor blockade. Model: Mouse acute slices, intrinsic-current measurements and knockout comparison. Limitations: High bath exposure; absence of effect in layer V reinforces cell-type specificity. Evidence access: Primary full text Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Complete structured claim and evidenceBlocking PKA or ERK signaling suppressed the glycine-associated increase in medium-spiny-neuron excitability; ERK and Kv7.2 serine phosphorylation increased in the study.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Mouse slice pharmacological inhibition and phosphorylation assays.
- limitations
- Associated phosphorylation and inhibitor effects do not establish every kinase-substrate step; cholinergic interneurons did not share the firing response.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The channel response depends on intracellular signaling steps.
- primary_references
- Glycine-induced activation of GPR158 increases the intrinsic excitability of medium spiny neurons in the nucleus accumbens. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38884814/ · DOI 10.1007/s00018-024-05260-w
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 266–272
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse slice pharmacological inhibition and phosphorylation assays. · source_derived_draft · unverified_draft
## glycine-gpr158-kinase-dependence The channel response depends on intracellular signaling steps. Blocking PKA or ERK signaling suppressed the glycine-associated increase in medium-spiny-neuron excitability; ERK and Kv7.2 serine phosphorylation increased in the study. Model: Mouse slice pharmacological inhibition and phosphorylation assays. Limitations: Associated phosphorylation and inhibitor effects do not establish every kinase-substrate step; cholinergic interneurons did not share the firing response. Evidence access: Primary full text Glycine-induced activation of GPR158 increases the intrinsic excitability of medium spiny neurons in the nucleus accumbens. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38884814/ · DOI 10.1007/s00018-024-05260-w
Complete structured claim and evidenceTaurine competed for GPR158 glycine binding and produced weaker cAMP suppression than glycine in the recombinant assays.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Membrane ligand competition and cell signaling.
- limitations
- Shared binding is not proof of supplement synergy or the same neuronal response.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Another nutrient-related molecule reaches the same receptor with a different response.
- primary_references
- Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 242–248
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Membrane ligand competition and cell signaling. · source_derived_draft · unverified_draft
## glycine-gpr158-taurine Another nutrient-related molecule reaches the same receptor with a different response. Taurine competed for GPR158 glycine binding and produced weaker cAMP suppression than glycine in the recombinant assays. Model: Membrane ligand competition and cell signaling. Limitations: Shared binding is not proof of supplement synergy or the same neuronal response. Evidence access: Primary full text Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36996198/ · DOI 10.1126/science.add7150
Complete structured claim and evidenceChloride-free buffer abolished the reported glycine effect, and 1 micromolar strychnine reversed it; glycine hyperpolarized the tested Kupffer cells.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat immune-cell ion substitution and antagonist experiments.
- limitations
- Pharmacology does not uniquely identify a receptor-subunit combination; high-dose strychnine behaved differently.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The ionic environment was required for the observed response.
- primary_references
- Kupffer cells contain a glycine-gated chloride channel. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9227496/ · DOI 10.1152/ajpgi.1997.272.6.G1581
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 338–344
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat immune-cell ion substitution and antagonist experiments. · source_derived_draft · unverified_draft
## glycine-kupffer-chloride-dependence The ionic environment was required for the observed response. Chloride-free buffer abolished the reported glycine effect, and 1 micromolar strychnine reversed it; glycine hyperpolarized the tested Kupffer cells. Model: Rat immune-cell ion substitution and antagonist experiments. Limitations: Pharmacology does not uniquely identify a receptor-subunit combination; high-dose strychnine behaved differently. Evidence access: Primary abstract Kupffer cells contain a glycine-gated chloride channel. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9227496/ · DOI 10.1152/ajpgi.1997.272.6.G1581
Complete structured claim and evidenceSLC6A20 mutations accompanied iminoglycinuria when combined with SLC36A2 variants retaining residual transport.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human family genotype/functional analysis.
- limitations
- Modifier evidence is not proof of ordinary dietary competition between glycine and proline.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A second transporter can change the effect of the first defect.
- primary_references
- Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. · 2008 · https://pubmed.ncbi.nlm.nih.gov/19033659/ · DOI 10.1172/JCI36625
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 74–80
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human family genotype/functional analysis. · source_derived_draft · unverified_draft
## glycine-renal-modifier A second transporter can change the effect of the first defect. SLC6A20 mutations accompanied iminoglycinuria when combined with SLC36A2 variants retaining residual transport. Model: Human family genotype/functional analysis. Limitations: Modifier evidence is not proof of ordinary dietary competition between glycine and proline. Evidence access: Primary abstract Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. · 2008 · https://pubmed.ncbi.nlm.nih.gov/19033659/ · DOI 10.1172/JCI36625
Complete structured claim and evidenceInheritance and functional studies in seven families implicated nonfunctional SLC36A2 alleles in urinary glycine and imino-acid loss; two defective alleles tracked iminoglycinuria and one tracked hyperglycinuria.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human family genetics with functional transporter testing.
- limitations
- This is renal handling; urinary loss alone does not establish systemic nutritional deficiency.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The kidney can lose glycine because its recovery transporter is faulty.
- primary_references
- Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. · 2008 · https://pubmed.ncbi.nlm.nih.gov/19033659/ · DOI 10.1172/JCI36625
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 66–72
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human family genetics with functional transporter testing. · source_derived_draft · unverified_draft
## glycine-renal-pat2 The kidney can lose glycine because its recovery transporter is faulty. Inheritance and functional studies in seven families implicated nonfunctional SLC36A2 alleles in urinary glycine and imino-acid loss; two defective alleles tracked iminoglycinuria and one tracked hyperglycinuria. Model: Human family genetics with functional transporter testing. Limitations: This is renal handling; urinary loss alone does not establish systemic nutritional deficiency. Evidence access: Primary abstract Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. · 2008 · https://pubmed.ncbi.nlm.nih.gov/19033659/ · DOI 10.1172/JCI36625
Complete structured claim and evidenceFormate at 1 mM rescued the low-B6 proliferation defect of SLC25A38-null K562 cells, while glycine, serine and folate did not under the tested conditions.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human leukemia cells, knockout and metabolite-rescue experiment.
- limitations
- Culture rescue is not a nutritional recommendation; this growth endpoint differs from zebrafish hemoglobin.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Restoring a downstream one-carbon source worked where adding an amino acid did not.
- primary_references
- SLC25A38 is required for mitochondrial pyridoxal 5'-phosphate (PLP) accumulation. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39856062/ · DOI 10.1038/s41467-025-56130-3
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 122–128
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human leukemia cells, knockout and metabolite-rescue experiment. · source_derived_draft · unverified_draft
## glycine-s38-formate-rescue Restoring a downstream one-carbon source worked where adding an amino acid did not. Formate at 1 mM rescued the low-B6 proliferation defect of SLC25A38-null K562 cells, while glycine, serine and folate did not under the tested conditions. Model: Human leukemia cells, knockout and metabolite-rescue experiment. Limitations: Culture rescue is not a nutritional recommendation; this growth endpoint differs from zebrafish hemoglobin. Evidence access: Primary full text SLC25A38 is required for mitochondrial pyridoxal 5'-phosphate (PLP) accumulation. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39856062/ · DOI 10.1038/s41467-025-56130-3
Complete structured claim and evidenceSLC25A38 loss reduced deuterated-serine incorporation into glycine and glycine-derived glutathione under low-B6 conditions.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human K562 knockout, isotope tracing and controlled B6 culture conditions.
- limitations
- Tracing reflects pathway flux; it does not establish direct PLP transport by SLC25A38.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A mitochondrial cofactor problem reduced the cell's ability to make glycine.
- primary_references
- SLC25A38 is required for mitochondrial pyridoxal 5'-phosphate (PLP) accumulation. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39856062/ · DOI 10.1038/s41467-025-56130-3
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 114–120
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human K562 knockout, isotope tracing and controlled B6 culture conditions. · source_derived_draft · unverified_draft
## glycine-s38-glycine-synthesis A mitochondrial cofactor problem reduced the cell's ability to make glycine. SLC25A38 loss reduced deuterated-serine incorporation into glycine and glycine-derived glutathione under low-B6 conditions. Model: Human K562 knockout, isotope tracing and controlled B6 culture conditions. Limitations: Tracing reflects pathway flux; it does not establish direct PLP transport by SLC25A38. Evidence access: Primary full text SLC25A38 is required for mitochondrial pyridoxal 5'-phosphate (PLP) accumulation. · 2025 · https://pubmed.ncbi.nlm.nih.gov/39856062/ · DOI 10.1038/s41467-025-56130-3
Complete structured claim and evidenceSHMT2 silencing combined with removal of extracellular glycine halted LOX IMVI proliferation; adding glycine restored growth whereas formate did not.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human melanoma cultures with shRNA and nutrient withdrawal/rescue.
- limitations
- A combined manipulation; not proof that ordinary dietary glycine alone controls a tumor.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- Removing both synthesis and external supply exposed a glycine dependency.
- primary_references
- Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22628656/ · DOI 10.1126/science.1218595
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 154–160
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human melanoma cultures with shRNA and nutrient withdrawal/rescue. · source_derived_draft · unverified_draft
## glycine-shmt2-glycine-dependence Removing both synthesis and external supply exposed a glycine dependency. SHMT2 silencing combined with removal of extracellular glycine halted LOX IMVI proliferation; adding glycine restored growth whereas formate did not. Model: Human melanoma cultures with shRNA and nutrient withdrawal/rescue. Limitations: A combined manipulation; not proof that ordinary dietary glycine alone controls a tumor. Evidence access: Primary full text Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22628656/ · DOI 10.1126/science.1218595
Complete structured claim and evidenceNMDA-receptor antagonists blocked glycine-associated cutaneous blood-flow responses in the rat experiments, whereas strychnine did not.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat brain injection and antagonist experiments.
- limitations
- Antagonist evidence supports pathway involvement; does not show all sleep effects use this route.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- The tested sleep-related response used a different receptor route from the inhibitory glycine channel.
- primary_references
- The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25533534/ · DOI 10.1038/npp.2014.326
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 418–424
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat brain injection and antagonist experiments. · source_derived_draft · unverified_draft
## glycine-sleep-nmda-route The tested sleep-related response used a different receptor route from the inhibitory glycine channel. NMDA-receptor antagonists blocked glycine-associated cutaneous blood-flow responses in the rat experiments, whereas strychnine did not. Model: Rat brain injection and antagonist experiments. Limitations: Antagonist evidence supports pathway involvement; does not show all sleep effects use this route. Evidence access: Primary abstract The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25533534/ · DOI 10.1038/npp.2014.326
Complete structured claim and evidenceGARS1 catalyzes glycyl-tRNA formation for glycine incorporation into cytosolic and mitochondrial proteins.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Established reaction described in a primary human GARS disease study.
- limitations
- Background enzyme chemistry is distinguished from the patient measurements; separate cytosolic/mitochondrial isoform kinetics were not measured here.
- nutrient_topic
- Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
- plain_language
- A charging enzyme attaches glycine to the RNA adapter used to build protein.
- primary_references
- Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28594869/ · DOI 10.1371/journal.pone.0178125
Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 386–392
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Established reaction described in a primary human GARS disease study. · source_derived_draft · unverified_draft
## glycine-trna-charging A charging enzyme attaches glycine to the RNA adapter used to build protein. GARS1 catalyzes glycyl-tRNA formation for glycine incorporation into cytosolic and mitochondrial proteins. Model: Established reaction described in a primary human GARS disease study. Limitations: Background enzyme chemistry is distinguished from the patient measurements; separate cytosolic/mitochondrial isoform kinetics were not measured here. Evidence access: Primary abstract Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28594869/ · DOI 10.1371/journal.pone.0178125
Complete structured claim and evidenceIsolated Slc25a32-null embryo mitochondria produced about 10.6% of control labeled formate from [13C2]-glycine over 24 hours.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- B2-dependent mitochondrial function supports glycine carbon entry into folate-related one-carbon supply.
- evidence_spans
- [{"source_bundle": "artifacts/riboflavin_metabolism_sources.json", "source_key": "PMC11072207", "locator": "HTML article p", "paragraph_index": 43, "char_start": 0, "char_end": 1215, "evidence_access": "full-text"}]
- experimental_model
- Slc25a32-null embryos and missense knock-in mice, isolated mitochondria and skeletal-muscle enzyme assays.
- exposure
- Slc25a32-null mitochondria supplied [1,2-13C2]-glycine.
- limitations
- Long isolated-mitochondrial assay; this is glycine-derived flux, not total cellular formate synthesis.
- nutrient_topic
- Riboflavin research collection; topical membership is not evidence of a direct dietary effect. · Riboflavin (vitamin B2)
- organism
- Mus musculus
- plain_language
- The same genetic defect sharply reduced one-carbon output from glycine.
- primary_references
- [peng-2022-slc25a32] Mitochondrial FAD shortage in SLC25A32 deficiency affects folate-mediated one-carbon metabolism (2022). https://pubmed.ncbi.nlm.nih.gov/35727412/ DOI: 10.1007/s00018-022-04404-0
- tissue_or_cell_type
- Embryo mitochondria, 24-hour isotope incubation
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Riboflavin: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 888–900
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Slc25a32-null embryos and missense knock-in mice, isolated mitochondria and skeletal-muscle enzyme assays. · source_derived_draft · unverified_draft
### b2-met-mouse-null-glycine-formate Isolated Slc25a32-null embryo mitochondria produced about 10.6% of control labeled formate from [13C2]-glycine over 24 hours. Condition category: machinery_impairment nutrient_topic: Riboflavin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The same genetic defect sharply reduced one-carbon output from glycine. organism: Mus musculus tissue_or_cell_type: Embryo mitochondria, 24-hour isotope incubation experimental_model: Slc25a32-null embryos and missense knock-in mice, isolated mitochondria and skeletal-muscle enzyme assays. limitations: Long isolated-mitochondrial assay; this is glycine-derived flux, not total cellular formate synthesis. exposure: Slc25a32-null mitochondria supplied [1,2-13C2]-glycine. cross_nutrient: B2-dependent mitochondrial function supports glycine carbon entry into folate-related one-carbon supply. evidence_spans: [{"source_bundle": "artifacts/riboflavin_metabolism_sources.json", "source_key": "PMC11072207", "locator": "HTML article p", "paragraph_index": 43, "char_start": 0, "char_end": 1215, "evidence_access": "full-text"}] [peng-2022-slc25a32] Mitochondrial FAD shortage in SLC25A32 deficiency affects folate-mediated one-carbon metabolism (2022). https://pubmed.ncbi.nlm.nih.gov/35727412/ DOI: 10.1007/s00018-022-04404-0
Complete structured claim and evidenceHost conjugation of microbially derived phenylacetate with glutamine produces PAGln, the predominant human conjugate in the study; glycine conjugation produces PAGly, predominant in mice.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human/mouse metabolomics study; established conjugation route described in primary full text.
- limitations
- This is not a purified conjugating-enzyme kinetic experiment and does not show clinically meaningful glutamine or glycine depletion.
- nutrient_topic
- L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
- plain_language
- Host amino acids help turn a bacterial product into circulating metabolites.
- primary_references
- A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32142679/ · DOI 10.1016/j.cell.2020.02.016
L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 358–364
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human/mouse metabolomics study; established conjugation route described in primary full text. · source_derived_draft · unverified_draft
## l-phenylalanine-host-conjugation Host amino acids help turn a bacterial product into circulating metabolites. Host conjugation of microbially derived phenylacetate with glutamine produces PAGln, the predominant human conjugate in the study; glycine conjugation produces PAGly, predominant in mice. Model: Human/mouse metabolomics study; established conjugation route described in primary full text. Limitations: This is not a purified conjugating-enzyme kinetic experiment and does not show clinically meaningful glutamine or glycine depletion. Evidence access: Primary full text A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32142679/ · DOI 10.1016/j.cell.2020.02.016
Complete structured claim and evidenceSerine-derived glycine supported glutathione synthesis required for optimal LPS-induced IL-1beta mRNA expression; inflammasome activation was not the affected step.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Mouse macrophage metabolic manipulation and LPS stimulation.
- limitations
- IL-1beta transcription and inflammasome-mediated processing are different endpoints.
- nutrient_topic
- L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Serine
- plain_language
- An antioxidant-building pathway can support inflammatory gene expression.
- primary_references
- Serine Metabolism Supports Macrophage IL-1β Production. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30773464/ · DOI 10.1016/j.cmet.2019.01.014
L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19) · lines 230–236
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse macrophage metabolic manipulation and LPS stimulation. · source_derived_draft · unverified_draft
## l-serine-macrophage-gsh An antioxidant-building pathway can support inflammatory gene expression. Serine-derived glycine supported glutathione synthesis required for optimal LPS-induced IL-1beta mRNA expression; inflammasome activation was not the affected step. Model: Mouse macrophage metabolic manipulation and LPS stimulation. Limitations: IL-1beta transcription and inflammasome-mediated processing are different endpoints. Evidence access: Primary abstract Serine Metabolism Supports Macrophage IL-1β Production. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30773464/ · DOI 10.1016/j.cmet.2019.01.014
Complete structured claim and evidencePatients with inherited PHGDH deficiency had low plasma and cerebrospinal-fluid serine, variably low glycine, microcephaly, seizures and severe developmental impairment.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Five-patient treatment follow-up in a rare inherited disorder.
- limitations
- This is not evidence that ordinary low dietary intake causes the same syndrome.
- nutrient_topic
- L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Serine
- plain_language
- An internal synthesis defect can create a clinically important shortage.
- primary_references
- Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids. · 2002 · https://pubmed.ncbi.nlm.nih.gov/12118526/ · DOI 10.1023/a:1015624726822
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19) · lines 86–92
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Five-patient treatment follow-up in a rare inherited disorder. · source_derived_draft · unverified_draft
## l-serine-phgdh-deficiency An internal synthesis defect can create a clinically important shortage. Patients with inherited PHGDH deficiency had low plasma and cerebrospinal-fluid serine, variably low glycine, microcephaly, seizures and severe developmental impairment. Model: Five-patient treatment follow-up in a rare inherited disorder. Limitations: This is not evidence that ordinary low dietary intake causes the same syndrome. Evidence access: Primary abstract Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids. · 2002 · https://pubmed.ncbi.nlm.nih.gov/12118526/ · DOI 10.1023/a:1015624726822
Complete structured claim and evidenceAmino-acid therapy over 3–7.5 years reduced seizure frequency in all five reported patients, with two becoming seizure-free; developmental progress was reported in only one early-treated patient.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Uncontrolled follow-up using different serine/glycine treatment regimens.
- limitations
- Small heterogeneous case series; no general supplement dose or guaranteed developmental rescue follows.
- nutrient_topic
- L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Serine
- plain_language
- Restoring supply can help some outcomes without reversing every consequence.
- primary_references
- Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids. · 2002 · https://pubmed.ncbi.nlm.nih.gov/12118526/ · DOI 10.1023/a:1015624726822
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19) · lines 94–100
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Uncontrolled follow-up using different serine/glycine treatment regimens. · source_derived_draft · unverified_draft
## l-serine-phgdh-treatment Restoring supply can help some outcomes without reversing every consequence. Amino-acid therapy over 3–7.5 years reduced seizure frequency in all five reported patients, with two becoming seizure-free; developmental progress was reported in only one early-treated patient. Model: Uncontrolled follow-up using different serine/glycine treatment regimens. Limitations: Small heterogeneous case series; no general supplement dose or guaranteed developmental rescue follows. Evidence access: Primary abstract Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids. · 2002 · https://pubmed.ncbi.nlm.nih.gov/12118526/ · DOI 10.1023/a:1015624726822
Complete structured claim and evidenceTwo siblings received serine plus glycine at different ages: the index child treated from 11 weeks died at seven months, whereas the sibling treated from birth had a normal reported outcome at age three.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Two siblings; reported regimens included serine 500 mg/kg/day and glycine 200 mg/kg/day.
- limitations
- Case comparison is not randomized proof, a universal rescue, or a dosing recommendation.
- nutrient_topic
- L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Serine
- plain_language
- Timing may matter when early development depends on local amino-acid supply.
- primary_references
- Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17436247/ · DOI 10.1086/517888
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19) · lines 110–116
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Two siblings; reported regimens included serine 500 mg/kg/day and glycine 200 mg/kg/day. · source_derived_draft · unverified_draft
## l-serine-psat-early-treatment Timing may matter when early development depends on local amino-acid supply. Two siblings received serine plus glycine at different ages: the index child treated from 11 weeks died at seven months, whereas the sibling treated from birth had a normal reported outcome at age three. Model: Two siblings; reported regimens included serine 500 mg/kg/day and glycine 200 mg/kg/day. Limitations: Case comparison is not randomized proof, a universal rescue, or a dosing recommendation. Evidence access: Primary abstract Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17436247/ · DOI 10.1086/517888
Complete structured claim and evidenceSFXN1-null human cells had impaired glycine and purine synthesis; loss of both SFXN1 and SFXN3 caused stronger defects, including dependence on exogenous glycine.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human cell single and double knockout comparisons.
- limitations
- Related transporters provide redundancy; this is not a demonstrated dietary serine deficiency.
- nutrient_topic
- L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Serine
- plain_language
- Transport capacity can limit another amino acid and nucleotide production.
- primary_references
- SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30442778/ · DOI 10.1126/science.aat9528
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19) · lines 150–156
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cell single and double knockout comparisons. · source_derived_draft · unverified_draft
## l-serine-sfxn1-loss Transport capacity can limit another amino acid and nucleotide production. SFXN1-null human cells had impaired glycine and purine synthesis; loss of both SFXN1 and SFXN3 caused stronger defects, including dependence on exogenous glycine. Model: Human cell single and double knockout comparisons. Limitations: Related transporters provide redundancy; this is not a demonstrated dietary serine deficiency. Evidence access: Primary abstract SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30442778/ · DOI 10.1126/science.aat9528
Complete structured claim and evidenceExtracellular serine supported optimal activated T-cell expansion by providing glycine and one-carbon units for nucleotide biosynthesis; adequate glucose alone did not substitute.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Primary study of activated T cells with in-vivo pathogen-driven expansion experiments in mice.
- limitations
- Species and activation context limit translation to human supplementation. Correction record: PubMed indexes a published erratum, PMID 28178570 / DOI 10.1016/j.cmet.2017.01.014. The notice body was not accessible during this curation, so its specific scope and impact remain unverified. Do not treat the original study as having received comprehensive integrity clearance. https://pubmed.ncbi.nlm.nih.gov/28178570/
- nutrient_topic
- L-Serine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Serine
- plain_language
- Fuel availability alone does not meet every requirement for immune-cell division.
- primary_references
- Serine Is an Essential Metabolite for Effector T Cell Expansion. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28111214/ · DOI 10.1016/j.cmet.2016.12.011
L-Serine: synthesis, one-carbon metabolism, lipids and cross-nutrient mechanisms (2026-09-19) · lines 214–220
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary study of activated T cells with in-vivo pathogen-driven expansion experiments in mice. · source_derived_draft · unverified_draft
## l-serine-tcell-expansion Fuel availability alone does not meet every requirement for immune-cell division. Extracellular serine supported optimal activated T-cell expansion by providing glycine and one-carbon units for nucleotide biosynthesis; adequate glucose alone did not substitute. Model: Primary study of activated T cells with in-vivo pathogen-driven expansion experiments in mice. Limitations: Species and activation context limit translation to human supplementation. Correction record: PubMed indexes a published erratum, PMID 28178570 / DOI 10.1016/j.cmet.2017.01.014. The notice body was not accessible during this curation, so its specific scope and impact remain unverified. Do not treat the original study as having received comprehensive integrity clearance. https://pubmed.ncbi.nlm.nih.gov/28178570/ Evidence access: Primary abstract Serine Is an Essential Metabolite for Effector T Cell Expansion. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28111214/ · DOI 10.1016/j.cmet.2016.12.011
Complete structured claim and evidenceMice carrying C-terminally truncated PTEN showed increased Slc6a20a expression, lower extracellular brain proline and glycine, and reduced NMDAR currents.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Engineered mouse PTEN model; transcriptional, microdialysis and electrophysiological observations.
- limitations
- Multiple consequences of PTEN mutation remain possible; the model is not ordinary dietary deficiency. Correction record: Author correction PMID 39242973 / DOI 10.1038/s44321-024-00125-y corrects the human embryonic stem-cell neuron protocol IRB approval number to KH2017-109 from KA2018-61 and KH2020-55. It does not report a change to experimental results. https://link.springer.com/article/10.1038/s44321-024-00125-y
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- Transporter regulation can alter the extracellular supply of two amino acids together.
- primary_references
- SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33428810/ · DOI 10.15252/emmm.202012632
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 214–220
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Engineered mouse PTEN model; transcriptional, microdialysis and electrophysiological observations. · source_derived_draft · unverified_draft
## l-proline-brain-transporter-increase Transporter regulation can alter the extracellular supply of two amino acids together. Mice carrying C-terminally truncated PTEN showed increased Slc6a20a expression, lower extracellular brain proline and glycine, and reduced NMDAR currents. Model: Engineered mouse PTEN model; transcriptional, microdialysis and electrophysiological observations. Limitations: Multiple consequences of PTEN mutation remain possible; the model is not ordinary dietary deficiency. Correction record: Author correction PMID 39242973 / DOI 10.1038/s44321-024-00125-y corrects the human embryonic stem-cell neuron protocol IRB approval number to KH2017-109 from KA2018-61 and KH2020-55. It does not report a change to experimental results. https://link.springer.com/article/10.1038/s44321-024-00125-y Evidence access: Primary full text SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33428810/ · DOI 10.15252/emmm.202012632
Complete structured claim and evidenceSelenium supplementation was required for the increased bacterial growth yield seen with the tested Stickland amino-acid pairs; proline-related acceptors induced selenoenzyme expression.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Anaerobic C. difficile culture in limiting medium; selenite supplementation and radiolabeled selenium protein analysis.
- limitations
- This bacterial growth mechanism does not establish that dietary selenium causes or prevents infection.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- Selenium also supports some microbial amino-acid fermentation pathways.
- primary_references
- Analysis of proline reduction in the nosocomial pathogen Clostridium difficile. · 2006 · https://pubmed.ncbi.nlm.nih.gov/17041035/ · DOI 10.1128/JB.01370-06
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 414–420
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Anaerobic C. difficile culture in limiting medium; selenite supplementation and radiolabeled selenium protein analysis. · source_derived_draft · unverified_draft
## l-proline-microbial-selenium Selenium also supports some microbial amino-acid fermentation pathways. Selenium supplementation was required for the increased bacterial growth yield seen with the tested Stickland amino-acid pairs; proline-related acceptors induced selenoenzyme expression. Model: Anaerobic C. difficile culture in limiting medium; selenite supplementation and radiolabeled selenium protein analysis. Limitations: This bacterial growth mechanism does not establish that dietary selenium causes or prevents infection. Evidence access: Primary abstract Analysis of proline reduction in the nosocomial pathogen Clostridium difficile. · 2006 · https://pubmed.ncbi.nlm.nih.gov/17041035/ · DOI 10.1128/JB.01370-06
Complete structured claim and evidenceSpermidine permeated activated GluN1/GluN2A and GluN1/GluN2B channels; reported Km values were 2.2 and 2.7 mM.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Receptors expressed in Xenopus oocytes and HEK293 cells; isotonic extracellular solutions.
- limitations
- Millimolar experimental kinetics are not physiological brain concentrations.
- nutrient_topic
- Spermidine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Spermidine
- plain_language
- A receptor channel can also provide an entry route.
- primary_references
- Spermidine and Ca(2+), but not Na(+), can permeate NMDA receptors consisting of GluN1 and GluN2A or GluN2B in the presence of Mg(2+). · 2015 · https://pubmed.ncbi.nlm.nih.gov/26086092/ · DOI 10.1016/j.bbrc.2015.06.081
Spermidine: biosynthesis, hypusination, transport and cross-nutrient mechanisms (2026-09-19) · lines 446–452
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Receptors expressed in Xenopus oocytes and HEK293 cells; isotonic extracellular solutions. · source_derived_draft · unverified_draft
## spermidine-nmda-entry A receptor channel can also provide an entry route. Spermidine permeated activated GluN1/GluN2A and GluN1/GluN2B channels; reported Km values were 2.2 and 2.7 mM. Model: Receptors expressed in Xenopus oocytes and HEK293 cells; isotonic extracellular solutions. Limitations: Millimolar experimental kinetics are not physiological brain concentrations. Evidence access: Primary abstract Spermidine and Ca(2+), but not Na(+), can permeate NMDA receptors consisting of GluN1 and GluN2A or GluN2B in the presence of Mg(2+). · 2015 · https://pubmed.ncbi.nlm.nih.gov/26086092/ · DOI 10.1016/j.bbrc.2015.06.081
Complete structured claim and evidenceLocal striatal theanine administration increased extracellular glycine.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/theanine-research/18196445.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "59fdaf94d59c2f4b2981c29cd2981c043351aae1299a59a19e29979076957839", "start_char": 0, "end_char": 1118, "text_sha256": "59fdaf94d59c2f4b2981c29cd2981c043351aae1299a59a19e29979076957839"}
- experimental_model
- In-vivo striatal microdialysis with receptor antagonists
- exposure
- Local brain theanine administration; glycine and AMPA antagonists
- limitations
- Direct brain dosing bypasses oral absorption and blood-brain-barrier transport. Antagonist sensitivity identifies pathway involvement, not necessarily direct theanine binding.
- nutrient_topic
- L-Theanine research collection; topical membership is not evidence of a direct dietary effect. · L-Theanine
- organism
- Conscious rats
- plain_language
- A measured local transmitter response is distinct from the effect of drinking tea.
- primary_references
- [theanine-p18196445] Theanine, gamma-glutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats. (2009). https://pubmed.ncbi.nlm.nih.gov/18196445/ DOI: 10.1007/s00726-007-0020-7
- tissue_or_cell_type
- Striatal extracellular neurotransmitters
L-Theanine: metabolism, neural signaling, nutrient connections and human outcomes (2026-09-17) · lines 367–378
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · In-vivo striatal microdialysis with receptor antagonists · source_derived_draft · unverified_draft
### theanine-striatal-glycine Local striatal theanine administration increased extracellular glycine. Condition category: normal nutrient_topic: L-Theanine research collection; topical membership is not evidence of a direct dietary effect. plain_language: A measured local transmitter response is distinct from the effect of drinking tea. organism: Conscious rats tissue_or_cell_type: Striatal extracellular neurotransmitters experimental_model: In-vivo striatal microdialysis with receptor antagonists limitations: Direct brain dosing bypasses oral absorption and blood-brain-barrier transport. Antagonist sensitivity identifies pathway involvement, not necessarily direct theanine binding. exposure: Local brain theanine administration; glycine and AMPA antagonists evidence_span: {"source_cache": "artifacts/theanine-research/18196445.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "59fdaf94d59c2f4b2981c29cd2981c043351aae1299a59a19e29979076957839", "start_char": 0, "end_char": 1118, "text_sha256": "59fdaf94d59c2f4b2981c29cd2981c043351aae1299a59a19e29979076957839"} [theanine-p18196445] Theanine, gamma-glutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats. (2009). https://pubmed.ncbi.nlm.nih.gov/18196445/ DOI: 10.1007/s00726-007-0020-7
Complete structured claim and evidenceHuman GLY1 contained frameshifting deletions and a premature stop codon; its mRNA was not detected, unlike the transcribed mouse homolog.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Comparative human and mouse gene characterization.
- limitations
- This does not exclude all possible promiscuous enzyme activity; it rejects treating canonical human GLY1 as an established active enzyme.
- nutrient_topic
- L-Threonine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Threonine
- plain_language
- A second proposed glycine-producing route also differs across species.
- primary_references
- Mice have a transcribed L-threonine aldolase/GLY1 gene, but the human GLY1 gene is a non-processed pseudogene. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15757516/ · DOI 10.1186/1471-2164-6-32
L-Threonine: translation, intestinal barrier, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 282–288
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Comparative human and mouse gene characterization. · source_derived_draft · unverified_draft
## l-threonine-human-aldolase-boundary A second proposed glycine-producing route also differs across species. Human GLY1 contained frameshifting deletions and a premature stop codon; its mRNA was not detected, unlike the transcribed mouse homolog. Model: Comparative human and mouse gene characterization. Limitations: This does not exclude all possible promiscuous enzyme activity; it rejects treating canonical human GLY1 as an established active enzyme. Evidence access: Primary abstract Mice have a transcribed L-threonine aldolase/GLY1 gene, but the human GLY1 gene is a non-processed pseudogene. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15757516/ · DOI 10.1186/1471-2164-6-32
Complete structured claim and evidenceHuman TDH transcripts encode truncated proteins because of splice-site disruption and a premature stop codon; the gene was classified as an expressed pseudogene.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human cDNA/genomic analysis; exon-6 splice-site loss in all 23 genotyped individuals.
- limitations
- Do not transfer intact mouse Tdh-dependent glycine and acetyl-CoA synthesis to humans.
- nutrient_topic
- L-Threonine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Threonine
- plain_language
- An expressed gene is not necessarily a functioning metabolic route.
- primary_references
- The human L-threonine 3-dehydrogenase gene is an expressed pseudogene. · 2002 · https://pubmed.ncbi.nlm.nih.gov/12361482/ · DOI 10.1186/1471-2156-3-18
L-Threonine: translation, intestinal barrier, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 274–280
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cDNA/genomic analysis; exon-6 splice-site loss in all 23 genotyped individuals. · source_derived_draft · unverified_draft
## l-threonine-human-tdh-boundary An expressed gene is not necessarily a functioning metabolic route. Human TDH transcripts encode truncated proteins because of splice-site disruption and a premature stop codon; the gene was classified as an expressed pseudogene. Model: Human cDNA/genomic analysis; exon-6 splice-site loss in all 23 genotyped individuals. Limitations: Do not transfer intact mouse Tdh-dependent glycine and acetyl-CoA synthesis to humans. Evidence access: Primary abstract The human L-threonine 3-dehydrogenase gene is an expressed pseudogene. · 2002 · https://pubmed.ncbi.nlm.nih.gov/12361482/ · DOI 10.1186/1471-2156-3-18
Complete structured claim and evidenceMouse embryonic stem cells expressed abundant Tdh and used mitochondrial threonine catabolism to support glycine and acetyl-CoA generation.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Mouse embryonic stem-cell metabolism and amino-acid withdrawal experiments.
- limitations
- Canonical human TDH is nonfunctional; this route is explicitly mouse-specific.
- nutrient_topic
- L-Threonine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Threonine
- plain_language
- A specialized mouse cell uses threonine as both carbon and one-carbon support.
- primary_references
- Dependence of mouse embryonic stem cells on threonine catabolism. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19589965/ · DOI 10.1126/science.1173288
L-Threonine: translation, intestinal barrier, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 322–328
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse embryonic stem-cell metabolism and amino-acid withdrawal experiments. · source_derived_draft · unverified_draft
## l-threonine-mouse-tdh-flux A specialized mouse cell uses threonine as both carbon and one-carbon support. Mouse embryonic stem cells expressed abundant Tdh and used mitochondrial threonine catabolism to support glycine and acetyl-CoA generation. Model: Mouse embryonic stem-cell metabolism and amino-acid withdrawal experiments. Limitations: Canonical human TDH is nonfunctional; this route is explicitly mouse-specific. Evidence access: Primary abstract Dependence of mouse embryonic stem cells on threonine catabolism. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19589965/ · DOI 10.1126/science.1173288
Complete structured claim and evidenceThreonine withdrawal reduced SAM accumulation and H3K4 trimethylation in mouse embryonic stem cells, with slower growth and increased differentiation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Mouse stem-cell isotope tracing and culture-medium withdrawal.
- limitations
- Do not generalize to all methylation marks, adult human tissues or a threonine treatment for methylation problems.
- nutrient_topic
- L-Threonine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Threonine
- plain_language
- A nutrient supply change altered a specific epigenetic mark in this cell model.
- primary_references
- Influence of threonine metabolism on S-adenosylmethionine and histone methylation. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23118012/ · DOI 10.1126/science.1226603
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Threonine: translation, intestinal barrier, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 330–336
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse stem-cell isotope tracing and culture-medium withdrawal. · source_derived_draft · unverified_draft
## l-threonine-mouse-threonine-methylation A nutrient supply change altered a specific epigenetic mark in this cell model. Threonine withdrawal reduced SAM accumulation and H3K4 trimethylation in mouse embryonic stem cells, with slower growth and increased differentiation. Model: Mouse stem-cell isotope tracing and culture-medium withdrawal. Limitations: Do not generalize to all methylation marks, adult human tissues or a threonine treatment for methylation problems. Evidence access: Primary abstract Influence of threonine metabolism on S-adenosylmethionine and histone methylation. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23118012/ · DOI 10.1126/science.1226603
Complete structured claim and evidenceCompared with age-adjusted controls, NKH patients had higher CSF threonine, lower serine and higher glycine.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- 61 genetically confirmed patients versus reference data from 274 controls; stereoselective serine analysis in a smaller subset.
- limitations
- Association does not identify a unique transport mechanism or justify treating an isolated CSF ratio.
- nutrient_topic
- L-Threonine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Threonine
- plain_language
- A high amino-acid measurement can accompany a defect in a neighboring pathway.
- primary_references
- Cerebrospinal fluid amino acids glycine, serine, and threonine in nonketotic hyperglycinemia. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35357708/ · DOI 10.1002/jimd.12500
- trigger_kind
- biomarker_context Imported condition classification; unverified.
L-Threonine: translation, intestinal barrier, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 418–424
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · 61 genetically confirmed patients versus reference data from 274 controls; stereoselective serine analysis in a smaller subset. · source_derived_draft · unverified_draft
## l-threonine-nkh-amino-acid-pattern A high amino-acid measurement can accompany a defect in a neighboring pathway. Compared with age-adjusted controls, NKH patients had higher CSF threonine, lower serine and higher glycine. Model: 61 genetically confirmed patients versus reference data from 274 controls; stereoselective serine analysis in a smaller subset. Limitations: Association does not identify a unique transport mechanism or justify treating an isolated CSF ratio. Evidence access: Primary abstract Cerebrospinal fluid amino acids glycine, serine, and threonine in nonketotic hyperglycinemia. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35357708/ · DOI 10.1002/jimd.12500
Complete structured claim and evidenceMice lacking the first and rate-limiting enzyme of creatine biosynthesis selectively in fat were prone to diet-induced obesity through suppression of the elevated energy expenditure normally seen with high-calorie feeding, with a blunted capacity for beta-3 adrenergic activation of metabolic rate that was rescued by dietary creatine supplementation.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/cold-research/28844881.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1341345f147cd7e59119d062b0523a4bf6087a6936b3434bb76a305033a724eb", "start_char": 0, "end_char": 1069, "text_sha256": "1341345f147cd7e59119d062b0523a4bf6087a6936b3434bb76a305033a724eb"}
- experimental_model
- Adipocyte-selective knockout of glycine amidinotransferase in mice
- exposure
- High-calorie feeding, beta-3 adrenergic activation, and dietary creatine supplementation
- limitations
- A genetic test of the same cycle with a dietary rescue. It concerns diet-induced thermogenesis rather than cold thermogenesis directly.
- nutrient_topic
- Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. · Cold water immersion
- organism
- Mouse
- plain_language
- Blocking the cell from making creatine caused obesity, and feeding creatine fixed it.
- primary_references
- [cold-p28844881] Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives Obesity. (2017). https://pubmed.ncbi.nlm.nih.gov/28844881/ DOI: 10.1016/j.cmet.2017.08.009
- tissue_or_cell_type
- Adipose tissue
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Cold water immersion: cold sensing, heat production, the catecholamine axis and what repeated exposure changes (2026-09-19) · lines 468–479
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Adipocyte-selective knockout of glycine amidinotransferase in mice · source_derived_draft · unverified_draft
### cold-gatm-knockout-obesity Mice lacking the first and rate-limiting enzyme of creatine biosynthesis selectively in fat were prone to diet-induced obesity through suppression of the elevated energy expenditure normally seen with high-calorie feeding, with a blunted capacity for beta-3 adrenergic activation of metabolic rate that was rescued by dietary creatine supplementation. Condition category: machinery_impairment nutrient_topic: Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. plain_language: Blocking the cell from making creatine caused obesity, and feeding creatine fixed it. organism: Mouse tissue_or_cell_type: Adipose tissue experimental_model: Adipocyte-selective knockout of glycine amidinotransferase in mice limitations: A genetic test of the same cycle with a dietary rescue. It concerns diet-induced thermogenesis rather than cold thermogenesis directly. exposure: High-calorie feeding, beta-3 adrenergic activation, and dietary creatine supplementation evidence_span: {"source_cache": "artifacts/cold-research/28844881.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1341345f147cd7e59119d062b0523a4bf6087a6936b3434bb76a305033a724eb", "start_char": 0, "end_char": 1069, "text_sha256": "1341345f147cd7e59119d062b0523a4bf6087a6936b3434bb76a305033a724eb"} [cold-p28844881] Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives Obesity. (2017). https://pubmed.ncbi.nlm.nih.gov/28844881/ DOI: 10.1016/j.cmet.2017.08.009
Complete structured claim and evidenceIncreasing GLS2 supported higher reduced-glutathione levels, lower reactive oxygen species and protection from peroxide-induced apoptosis in the reported cell experiments.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human-cell GLS2/p53 and oxidative-stress experiments.
- limitations
- Cysteine, glycine and synthesis machinery remain necessary; glutamate is not established as the universal limiting substrate.
- nutrient_topic
- L-Glutamate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Glutamate
- plain_language
- The same supply route fed antioxidant chemistry as well as energy metabolism.
- primary_references
- Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20378837/ · DOI 10.1073/pnas.1001006107
L-Glutamate / L-glutamic acid: carbon and nitrogen allocation, signaling and cross-nutrient mechanisms (2026-09-19) · lines 226–232
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human-cell GLS2/p53 and oxidative-stress experiments. · source_derived_draft · unverified_draft
## glutamate-gls2-gsh The same supply route fed antioxidant chemistry as well as energy metabolism. Increasing GLS2 supported higher reduced-glutathione levels, lower reactive oxygen species and protection from peroxide-induced apoptosis in the reported cell experiments. Model: Human-cell GLS2/p53 and oxidative-stress experiments. Limitations: Cysteine, glycine and synthesis machinery remain necessary; glutamate is not established as the universal limiting substrate. Evidence access: Primary abstract Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20378837/ · DOI 10.1073/pnas.1001006107
Complete structured claim and evidencePurified human SHMT1 cleaves hydroxytrimethyllysine into trimethylaminobutyraldehyde and glycine.
Experimental context and source evidence
- experimental_model
- Purified human enzyme; NMR and coupled activity assays
- limitations
- Whole-body flux contribution remains unquantified.
- organism
- Homo sapiens
- plain_language
- SHMT1 can perform the second carnitine-synthesis reaction.
- primary_references
- [osmes2024] One substrate many enzymes virtual screening uncovers missing genes of carnitine biosynthesis in human and mouse (2024). https://www.nature.com/articles/s41467-024-47466-3 DOI: 10.1038/s41467-024-47466-3
- tissue_or_cell_type
- Cytosolic enzyme tested in vitro
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 177–185
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human enzyme; NMR and coupled activity assays · source_derived_draft · unverified_draft
### shmt1-html-cleavage Purified human SHMT1 cleaves hydroxytrimethyllysine into trimethylaminobutyraldehyde and glycine. Plain language: SHMT1 can perform the second carnitine-synthesis reaction. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Cytosolic enzyme tested in vitro experimental_model: Purified human enzyme; NMR and coupled activity assays limitations: Whole-body flux contribution remains unquantified. [osmes2024] One substrate many enzymes virtual screening uncovers missing genes of carnitine biosynthesis in human and mouse (2024). https://www.nature.com/articles/s41467-024-47466-3 DOI: 10.1038/s41467-024-47466-3
Complete structured claim and evidencePurified human SHMT2 also cleaves hydroxytrimethyllysine, with lower measured catalytic efficiency than SHMT1.
Experimental context and source evidence
- experimental_model
- Purified human enzyme kinetic assay
- limitations
- Mouse Tha1 specialization should not be assigned to a human THA1 enzyme.
- organism
- Homo sapiens
- plain_language
- SHMT2 provides another demonstrated aldolase activity.
- primary_references
- [osmes2024] One substrate many enzymes virtual screening uncovers missing genes of carnitine biosynthesis in human and mouse (2024). https://www.nature.com/articles/s41467-024-47466-3 DOI: 10.1038/s41467-024-47466-3
- tissue_or_cell_type
- Mitochondrial enzyme tested in vitro
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 187–195
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human enzyme kinetic assay · source_derived_draft · unverified_draft
### shmt2-html-cleavage Purified human SHMT2 also cleaves hydroxytrimethyllysine, with lower measured catalytic efficiency than SHMT1. Plain language: SHMT2 provides another demonstrated aldolase activity. Condition category: normal organism: Homo sapiens tissue_or_cell_type: Mitochondrial enzyme tested in vitro experimental_model: Purified human enzyme kinetic assay limitations: Mouse Tha1 specialization should not be assigned to a human THA1 enzyme. [osmes2024] One substrate many enzymes virtual screening uncovers missing genes of carnitine biosynthesis in human and mouse (2024). https://www.nature.com/articles/s41467-024-47466-3 DOI: 10.1038/s41467-024-47466-3
Complete structured claim and evidenceGlyNAC did not significantly improve the GSH:GSSG ratio; high-dose versus placebo p=0.739.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/35821844.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3", "start_char": 0, "end_char": 2083, "text_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3"}
- experimental_model
- Randomized controlled dose-ranging trial
- exposure
- 2.4, 4.8 or 7.2 g/day GlyNAC, 1:1 ratio, for two weeks
- limitations
- Primary outcomes were null; the favorable low-GSH/high-MDA subgroup was post hoc and hypothesis-generating.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- Adding precursors did not reliably improve redox status in the overall trial.
- primary_references
- [glutathione-p35821844] A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. (2022). https://pubmed.ncbi.nlm.nih.gov/35821844/ DOI: 10.3389/fragi.2022.852569
- tissue_or_cell_type
- 114 healthy older volunteers; 20 young reference participants
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1256–1267
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized controlled dose-ranging trial · source_derived_draft · unverified_draft
### glutathione-glynac-large-ratio-null GlyNAC did not significantly improve the GSH:GSSG ratio; high-dose versus placebo p=0.739. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: Adding precursors did not reliably improve redox status in the overall trial. organism: Human tissue_or_cell_type: 114 healthy older volunteers; 20 young reference participants experimental_model: Randomized controlled dose-ranging trial limitations: Primary outcomes were null; the favorable low-GSH/high-MDA subgroup was post hoc and hypothesis-generating. exposure: 2.4, 4.8 or 7.2 g/day GlyNAC, 1:1 ratio, for two weeks evidence_span: {"source_cache": "artifacts/glutathione-research/35821844.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3", "start_char": 0, "end_char": 2083, "text_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3"} [glutathione-p35821844] A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. (2022). https://pubmed.ncbi.nlm.nih.gov/35821844/ DOI: 10.3389/fragi.2022.852569
Complete structured claim and evidenceThe primary total-GSH endpoint was not significantly increased; high-dose versus placebo p=0.278.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/35821844.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3", "start_char": 0, "end_char": 2083, "text_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3"}
- experimental_model
- Randomized controlled dose-ranging trial
- exposure
- 2.4, 4.8 or 7.2 g/day GlyNAC, 1:1 ratio, for two weeks
- limitations
- Primary outcomes were null; the favorable low-GSH/high-MDA subgroup was post hoc and hypothesis-generating.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- The main trial result must remain visible alongside favorable subsets.
- primary_references
- [glutathione-p35821844] A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. (2022). https://pubmed.ncbi.nlm.nih.gov/35821844/ DOI: 10.3389/fragi.2022.852569
- tissue_or_cell_type
- 114 healthy older volunteers; 20 young reference participants
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1269–1280
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized controlled dose-ranging trial · source_derived_draft · unverified_draft
### glutathione-glynac-large-total-null The primary total-GSH endpoint was not significantly increased; high-dose versus placebo p=0.278. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: The main trial result must remain visible alongside favorable subsets. organism: Human tissue_or_cell_type: 114 healthy older volunteers; 20 young reference participants experimental_model: Randomized controlled dose-ranging trial limitations: Primary outcomes were null; the favorable low-GSH/high-MDA subgroup was post hoc and hypothesis-generating. exposure: 2.4, 4.8 or 7.2 g/day GlyNAC, 1:1 ratio, for two weeks evidence_span: {"source_cache": "artifacts/glutathione-research/35821844.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3", "start_char": 0, "end_char": 2083, "text_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3"} [glutathione-p35821844] A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. (2022). https://pubmed.ncbi.nlm.nih.gov/35821844/ DOI: 10.3389/fragi.2022.852569
Complete structured claim and evidenceA post-hoc high-MDA/low-baseline-GSH subgroup had higher total GSH with pooled medium/high doses (p=0.016).
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/35821844.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3", "start_char": 0, "end_char": 2083, "text_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3"}
- experimental_model
- Randomized controlled dose-ranging trial
- exposure
- 2.4, 4.8 or 7.2 g/day GlyNAC, 1:1 ratio, for two weeks
- limitations
- Primary outcomes were null; the favorable low-GSH/high-MDA subgroup was post hoc and hypothesis-generating.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- A subgroup signal needs confirmation in a prespecified trial.
- primary_references
- [glutathione-p35821844] A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. (2022). https://pubmed.ncbi.nlm.nih.gov/35821844/ DOI: 10.3389/fragi.2022.852569
- tissue_or_cell_type
- 114 healthy older volunteers; 20 young reference participants
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1282–1293
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized controlled dose-ranging trial · source_derived_draft · unverified_draft
### glutathione-glynac-posthoc A post-hoc high-MDA/low-baseline-GSH subgroup had higher total GSH with pooled medium/high doses (p=0.016). Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: A subgroup signal needs confirmation in a prespecified trial. organism: Human tissue_or_cell_type: 114 healthy older volunteers; 20 young reference participants experimental_model: Randomized controlled dose-ranging trial limitations: Primary outcomes were null; the favorable low-GSH/high-MDA subgroup was post hoc and hypothesis-generating. exposure: 2.4, 4.8 or 7.2 g/day GlyNAC, 1:1 ratio, for two weeks evidence_span: {"source_cache": "artifacts/glutathione-research/35821844.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3", "start_char": 0, "end_char": 2083, "text_sha256": "843ee2e21e49023605a628216fb9c3c4c69ca1d8f3bb19d10da85d038d6612f3"} [glutathione-p35821844] A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage. (2022). https://pubmed.ncbi.nlm.nih.gov/35821844/ DOI: 10.3389/fragi.2022.852569
Complete structured claim and evidenceInvestigators reported improved physical-function assessments with GlyNAC but not placebo.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/35975308.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13989143c2c7c77d97a84aaebdf1cb2b22fc4e44c8acb09c4f9ed3b8134b1088", "start_char": 0, "end_char": 1950, "text_sha256": "13989143c2c7c77d97a84aaebdf1cb2b22fc4e44c8acb09c4f9ed3b8134b1088"}
- experimental_model
- Randomized placebo-controlled trial in older adults
- exposure
- Sixteen-week GlyNAC versus isonitrogenous alanine placebo
- limitations
- Small trial, many outcomes; no demonstrated lifespan extension. Reference young group was not an additional older randomized arm.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- Functional signals accompany the biochemical result, with replication still needed.
- primary_references
- [glutathione-p35975308] Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. (2023). https://pubmed.ncbi.nlm.nih.gov/35975308/ DOI: 10.1093/gerona/glac135
- tissue_or_cell_type
- 24 older adults randomized 12 per arm; 12 young reference participants
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1308–1319
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled trial in older adults · source_derived_draft · unverified_draft
### glutathione-glynac-small-function Investigators reported improved physical-function assessments with GlyNAC but not placebo. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: Functional signals accompany the biochemical result, with replication still needed. organism: Human tissue_or_cell_type: 24 older adults randomized 12 per arm; 12 young reference participants experimental_model: Randomized placebo-controlled trial in older adults limitations: Small trial, many outcomes; no demonstrated lifespan extension. Reference young group was not an additional older randomized arm. exposure: Sixteen-week GlyNAC versus isonitrogenous alanine placebo evidence_span: {"source_cache": "artifacts/glutathione-research/35975308.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13989143c2c7c77d97a84aaebdf1cb2b22fc4e44c8acb09c4f9ed3b8134b1088", "start_char": 0, "end_char": 1950, "text_sha256": "13989143c2c7c77d97a84aaebdf1cb2b22fc4e44c8acb09c4f9ed3b8134b1088"} [glutathione-p35975308] Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. (2023). https://pubmed.ncbi.nlm.nih.gov/35975308/ DOI: 10.1093/gerona/glac135
Complete structured claim and evidenceThe older GlyNAC group improved measured GSH deficiency relative to the placebo pattern.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/35975308.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13989143c2c7c77d97a84aaebdf1cb2b22fc4e44c8acb09c4f9ed3b8134b1088", "start_char": 0, "end_char": 1950, "text_sha256": "13989143c2c7c77d97a84aaebdf1cb2b22fc4e44c8acb09c4f9ed3b8134b1088"}
- experimental_model
- Randomized placebo-controlled trial in older adults
- exposure
- Sixteen-week GlyNAC versus isonitrogenous alanine placebo
- limitations
- Small trial, many outcomes; no demonstrated lifespan extension. Reference young group was not an additional older randomized arm.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- The small longer trial reported a biochemical benefit.
- primary_references
- [glutathione-p35975308] Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. (2023). https://pubmed.ncbi.nlm.nih.gov/35975308/ DOI: 10.1093/gerona/glac135
- tissue_or_cell_type
- 24 older adults randomized 12 per arm; 12 young reference participants
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1295–1306
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled trial in older adults · source_derived_draft · unverified_draft
### glutathione-glynac-small-gsh The older GlyNAC group improved measured GSH deficiency relative to the placebo pattern. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: The small longer trial reported a biochemical benefit. organism: Human tissue_or_cell_type: 24 older adults randomized 12 per arm; 12 young reference participants experimental_model: Randomized placebo-controlled trial in older adults limitations: Small trial, many outcomes; no demonstrated lifespan extension. Reference young group was not an additional older randomized arm. exposure: Sixteen-week GlyNAC versus isonitrogenous alanine placebo evidence_span: {"source_cache": "artifacts/glutathione-research/35975308.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13989143c2c7c77d97a84aaebdf1cb2b22fc4e44c8acb09c4f9ed3b8134b1088", "start_char": 0, "end_char": 1950, "text_sha256": "13989143c2c7c77d97a84aaebdf1cb2b22fc4e44c8acb09c4f9ed3b8134b1088"} [glutathione-p35975308] Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. (2023). https://pubmed.ncbi.nlm.nih.gov/35975308/ DOI: 10.1093/gerona/glac135
Complete structured claim and evidenceThe absolute erythrocyte GSH synthesis rate increased 230.9% after supplementation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/glutathione-research/21795440.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd", "start_char": 0, "end_char": 2139, "text_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd"}
- experimental_model
- Stable-isotope tracer study with before/after supplementation
- exposure
- Two weeks of glycine/cysteine-precursor supplementation in older participants
- limitations
- Small non-placebo-controlled intervention; age comparison and treatment response are not universal aging rules.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- The measured amount produced also increased.
- primary_references
- [glutathione-p21795440] Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. (2011). https://pubmed.ncbi.nlm.nih.gov/21795440/ DOI: 10.3945/ajcn.110.003483
- tissue_or_cell_type
- Eight older and eight younger adults; erythrocytes
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1113–1124
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope tracer study with before/after supplementation · source_derived_draft · unverified_draft
### glutathione-precursor-absolute-synthesis The absolute erythrocyte GSH synthesis rate increased 230.9% after supplementation. Condition category: nutrient_deficiency nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: The measured amount produced also increased. organism: Human tissue_or_cell_type: Eight older and eight younger adults; erythrocytes experimental_model: Stable-isotope tracer study with before/after supplementation limitations: Small non-placebo-controlled intervention; age comparison and treatment response are not universal aging rules. exposure: Two weeks of glycine/cysteine-precursor supplementation in older participants evidence_span: {"source_cache": "artifacts/glutathione-research/21795440.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd", "start_char": 0, "end_char": 2139, "text_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd"} [glutathione-p21795440] Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. (2011). https://pubmed.ncbi.nlm.nih.gov/21795440/ DOI: 10.3945/ajcn.110.003483
Complete structured claim and evidenceThe older group’s erythrocyte GSH concentration increased 94.6% after supplementation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/glutathione-research/21795440.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd", "start_char": 0, "end_char": 2139, "text_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd"}
- experimental_model
- Stable-isotope tracer study with before/after supplementation
- exposure
- Two weeks of glycine/cysteine-precursor supplementation in older participants
- limitations
- Small non-placebo-controlled intervention; age comparison and treatment response are not universal aging rules.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- A low measured pool increased in this small study.
- primary_references
- [glutathione-p21795440] Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. (2011). https://pubmed.ncbi.nlm.nih.gov/21795440/ DOI: 10.3945/ajcn.110.003483
- tissue_or_cell_type
- Eight older and eight younger adults; erythrocytes
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1126–1137
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope tracer study with before/after supplementation · source_derived_draft · unverified_draft
### glutathione-precursor-pool The older group’s erythrocyte GSH concentration increased 94.6% after supplementation. Condition category: nutrient_deficiency nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: A low measured pool increased in this small study. organism: Human tissue_or_cell_type: Eight older and eight younger adults; erythrocytes experimental_model: Stable-isotope tracer study with before/after supplementation limitations: Small non-placebo-controlled intervention; age comparison and treatment response are not universal aging rules. exposure: Two weeks of glycine/cysteine-precursor supplementation in older participants evidence_span: {"source_cache": "artifacts/glutathione-research/21795440.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd", "start_char": 0, "end_char": 2139, "text_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd"} [glutathione-p21795440] Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. (2011). https://pubmed.ncbi.nlm.nih.gov/21795440/ DOI: 10.3945/ajcn.110.003483
Complete structured claim and evidenceAfter supplementation, older participants had a 78.8% higher fractional GSH synthesis rate.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/glutathione-research/21795440.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd", "start_char": 0, "end_char": 2139, "text_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd"}
- experimental_model
- Stable-isotope tracer study with before/after supplementation
- exposure
- Two weeks of glycine/cysteine-precursor supplementation in older participants
- limitations
- Small non-placebo-controlled intervention; age comparison and treatment response are not universal aging rules.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human
- plain_language
- The fraction of the pool synthesized each day increased.
- primary_references
- [glutathione-p21795440] Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. (2011). https://pubmed.ncbi.nlm.nih.gov/21795440/ DOI: 10.3945/ajcn.110.003483
- tissue_or_cell_type
- Eight older and eight younger adults; erythrocytes
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 1100–1111
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope tracer study with before/after supplementation · source_derived_draft · unverified_draft
### glutathione-precursor-synthesis After supplementation, older participants had a 78.8% higher fractional GSH synthesis rate. Condition category: nutrient_deficiency nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: The fraction of the pool synthesized each day increased. organism: Human tissue_or_cell_type: Eight older and eight younger adults; erythrocytes experimental_model: Stable-isotope tracer study with before/after supplementation limitations: Small non-placebo-controlled intervention; age comparison and treatment response are not universal aging rules. exposure: Two weeks of glycine/cysteine-precursor supplementation in older participants evidence_span: {"source_cache": "artifacts/glutathione-research/21795440.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd", "start_char": 0, "end_char": 2139, "text_sha256": "97479748f2fecc462981498968c43dd6199dcdb9c7f91a2118d98695fc0087dd"} [glutathione-p21795440] Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. (2011). https://pubmed.ncbi.nlm.nih.gov/21795440/ DOI: 10.3945/ajcn.110.003483
Complete structured claim and evidenceL-aspartate evoked currents from recombinant rat GluN1/GluN2D receptors expressed in HEK293 cells when glycine was present.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Rat receptor constructs; 1-second 1 mM agonist pulse with 0.05 mM glycine.
- limitations
- This does not demonstrate brain entry, cognitive benefit or excitotoxicity after oral intake.
- nutrient_topic
- L-Aspartate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Aspartate
- plain_language
- L-aspartate can act at a receptor in a controlled electrophysiology experiment.
- primary_references
- Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21522138/ · DOI 10.1038/ncomms1295
L-Aspartate: redox transfer, nitrogen partitioning and cross-nutrient mechanisms (2026-09-19) · lines 394–400
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat receptor constructs; 1-second 1 mM agonist pulse with 0.05 mM glycine. · source_derived_draft · unverified_draft
## l-aspartate-nmda-agonism L-aspartate can act at a receptor in a controlled electrophysiology experiment. L-aspartate evoked currents from recombinant rat GluN1/GluN2D receptors expressed in HEK293 cells when glycine was present. Model: Rat receptor constructs; 1-second 1 mM agonist pulse with 0.05 mM glycine. Limitations: This does not demonstrate brain entry, cognitive benefit or excitotoxicity after oral intake. Evidence access: Primary full text Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21522138/ · DOI 10.1038/ncomms1295
Complete structured claim and evidenceL-aspartate-evoked GluN1/GluN2D currents deactivated faster than L-glutamate-evoked currents under matched recording conditions.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Rat recombinant receptors in HEK293 cells; voltage-clamp and structural comparisons.
- limitations
- Not a universal rank of potency or toxicity across all NMDA receptor subtypes.
- nutrient_topic
- L-Aspartate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Aspartate
- plain_language
- Two agonists at the same receptor can produce different signal durations.
- primary_references
- Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21522138/ · DOI 10.1038/ncomms1295
L-Aspartate: redox transfer, nitrogen partitioning and cross-nutrient mechanisms (2026-09-19) · lines 402–408
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Rat recombinant receptors in HEK293 cells; voltage-clamp and structural comparisons. · source_derived_draft · unverified_draft
## l-aspartate-nmda-deactivation Two agonists at the same receptor can produce different signal durations. L-aspartate-evoked GluN1/GluN2D currents deactivated faster than L-glutamate-evoked currents under matched recording conditions. Model: Rat recombinant receptors in HEK293 cells; voltage-clamp and structural comparisons. Limitations: Not a universal rank of potency or toxicity across all NMDA receptor subtypes. Evidence access: Primary full text Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21522138/ · DOI 10.1038/ncomms1295
Complete structured claim and evidenceALDH1L1-expressing HuH-7 cells had lower serine and higher glycine than controls.
Experimental context and source evidence
- experimental_model
- Cell metabolomics
- exposure
- Engineered ALDH1L1 expression.
- limitations
- Pool changes alone do not quantify compartment-specific SHMT flux.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- Changing folate-carbon disposal reshaped amino-acid pools.
- primary_references
- [sasaki-2023] One-carbon metabolizing enzyme ALDH1L1 influences mitochondrial metabolism through 5-aminoimidazole-4-carboxamide ribonucleotide accumulation and serine depletion, contributing to tumor suppression (2023). https://pubmed.ncbi.nlm.nih.gov/37596270/ DOI: 10.1038/s41598-023-38142-5
- tissue_or_cell_type
- HuH-7 cells
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1084–1094
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell metabolomics · source_derived_draft · unverified_draft
### aldh1l1-serine-glycine ALDH1L1-expressing HuH-7 cells had lower serine and higher glycine than controls. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Changing folate-carbon disposal reshaped amino-acid pools. organism: Homo sapiens tissue_or_cell_type: HuH-7 cells experimental_model: Cell metabolomics limitations: Pool changes alone do not quantify compartment-specific SHMT flux. exposure: Engineered ALDH1L1 expression. [sasaki-2023] One-carbon metabolizing enzyme ALDH1L1 influences mitochondrial metabolism through 5-aminoimidazole-4-carboxamide ribonucleotide accumulation and serine depletion, contributing to tumor suppression (2023). https://pubmed.ncbi.nlm.nih.gov/37596270/ DOI: 10.1038/s41598-023-38142-5
Complete structured claim and evidenceMitochondrial-only FPGS expression relieved the glycine supplementation requirement of AUXB1 cells.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- experimental_model
- Human FPGS isoforms in Chinese hamster AUXB1 cells
- exposure
- Mitochondrial FPGS reconstitution with nutrient complementation
- limitations
- Growth complementation is indirect evidence of glycine synthetic capacity.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Human enzyme in Cricetulus griseus cells
- plain_language
- Restoring mitochondrial folate retention restored glycine independence.
- primary_references
- [lawrence2014] Mammalian mitochondrial and cytosolic folylpolyglutamate synthetase maintain the subcellular compartmentalization of folates (2014). https://pubmed.ncbi.nlm.nih.gov/25164808/ DOI: 10.1074/jbc.m114.593244
- tissue_or_cell_type
- AUXB1 cells
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 315–325
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human FPGS isoforms in Chinese hamster AUXB1 cells · source_derived_draft · unverified_draft
### folate-fpgs-mito-glycine-complementation Mitochondrial-only FPGS expression relieved the glycine supplementation requirement of AUXB1 cells. Condition category: machinery_impairment nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Restoring mitochondrial folate retention restored glycine independence. organism: Human enzyme in Cricetulus griseus cells tissue_or_cell_type: AUXB1 cells experimental_model: Human FPGS isoforms in Chinese hamster AUXB1 cells limitations: Growth complementation is indirect evidence of glycine synthetic capacity. exposure: Mitochondrial FPGS reconstitution with nutrient complementation [lawrence2014] Mammalian mitochondrial and cytosolic folylpolyglutamate synthetase maintain the subcellular compartmentalization of folates (2014). https://pubmed.ncbi.nlm.nih.gov/25164808/ DOI: 10.1074/jbc.m114.593244
Complete structured claim and evidenceRat GNMT activity assays measured SAM-dependent glycine methylation to sarcosine.
Experimental context and source evidence
- experimental_model
- Native rat liver and bacterially expressed rat GNMT.
- limitations
- Does not quantify whole-body methyl demand.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Rattus norvegicus
- plain_language
- GNMT spends a SAM methyl group on glycine.
- primary_references
- [luka-2008] Acetylation of N-terminal valine of glycine N-methyltransferase affects enzyme inhibition by folate (2008). https://pubmed.ncbi.nlm.nih.gov/18501206/ DOI: 10.1016/j.bbapap.2008.04.016
- tissue_or_cell_type
- Native/recombinant rat enzyme
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 756–765
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Native rat liver and bacterially expressed rat GNMT. · source_derived_draft · unverified_draft
### folate-methyl-gnmt-methyl-use Rat GNMT activity assays measured SAM-dependent glycine methylation to sarcosine. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: GNMT spends a SAM methyl group on glycine. organism: Rattus norvegicus tissue_or_cell_type: Native/recombinant rat enzyme experimental_model: Native rat liver and bacterially expressed rat GNMT. limitations: Does not quantify whole-body methyl demand. [luka-2008] Acetylation of N-terminal valine of glycine N-methyltransferase affects enzyme inhibition by folate (2008). https://pubmed.ncbi.nlm.nih.gov/18501206/ DOI: 10.1016/j.bbapap.2008.04.016
Complete structured claim and evidenceIn nutrient-replete HEK293T and HCT116 cells, isotope tracing showed net SHMT1 flux toward serine synthesis.
Experimental context and source evidence
- cross_nutrient
- Links existing B6-dependent SHMT chemistry to folate flux direction.
- experimental_model
- Stable-isotope tracing
- exposure
- Assay conditions described in the linked primary study.
- limitations
- Not a universal direction across tissues or nutrition states.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- SHMT1 can consume one-carbon units instead of producing them.
- primary_references
- [ducker-2016] Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway (2016). https://pubmed.ncbi.nlm.nih.gov/27211901/ DOI: 10.1016/j.cmet.2016.04.016
- tissue_or_cell_type
- HEK293T and HCT116 cells
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 923–934
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stable-isotope tracing · source_derived_draft · unverified_draft
### shmt1-reverse-flux-replete In nutrient-replete HEK293T and HCT116 cells, isotope tracing showed net SHMT1 flux toward serine synthesis. Condition category: normal nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: SHMT1 can consume one-carbon units instead of producing them. organism: Homo sapiens tissue_or_cell_type: HEK293T and HCT116 cells experimental_model: Stable-isotope tracing limitations: Not a universal direction across tissues or nutrition states. exposure: Assay conditions described in the linked primary study. cross_nutrient: Links existing B6-dependent SHMT chemistry to folate flux direction. [ducker-2016] Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway (2016). https://pubmed.ncbi.nlm.nih.gov/27211901/ DOI: 10.1016/j.cmet.2016.04.016
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.